{"entity_poly": {"nstd_linkage": "no", "nstd_monomer": "no", "pdbx_seq_one_letter_code": "MDRASELLFYVNGRKVIEKNVDPETMLLPYLRKKLRLTGTKYGCGGGGCGACTVMISRYNPITKRIRHHPANACLIPICSLYGAAVTTVEGIGSTHTRIHPVQERIAKCHGTQCGFCTPGMVMSIYTLLRNHPEPTLDQLTDALGGNLCRCTGYRPIIDACKTFCKTSGCCQSKENGVCCLDQGINGLPEFEEGSKTSPKLFAEEEFLPLDPTQELIFPPELMIMAEKQSQRTRVFGSERMMWFSPVTLKELLEFKFKYPQAPVIMGNTSVGPEVKFKGVFHPVIISPDRIEELSVVNHAYNGLTLGAGLSLAQVKDILADVVQKLPEEKTQMYHALLKHLGTLAGSQIRNMASLGGHIISRHPDSDLNPILAVGNCTLNLLSKEGKRQIPLNEQFLSKCPNADLKPQEILVSVNIPYSRKWEFVSAFRQAQRQENALAIVNSGMRVFFGEGDGIIRELCISYGGVGPATICAKNSCQKLIGRHWNEQMLDIACRLILNEVSLLGSAPGGKVEFKRTLIISFLFKFYLEVSQILKKMDPVHYPSLADKYESALEDLHSKHHCSTLKYQNIGPKQHPEDPIGHPIMHLSGVKHATGEAIYCDDMPLVDQELFLTFVTSSRAHAKIVSIDLSEALSMPGVVDIMTAEHLSDVNSFCFFTEAEKFLATDKVFCVGQLVCAVLADSEVQAKRAAKRVKIVYQDLEPLILTIEESIQHNSSFKPERKLEYGNVDEAFKVVDQILEGEIHMGGQEHFYMETQSMLVVPKGEDQEMDVYVSTQFPKYIQDIVASTLKLPANKVMCHVRRVGGAFGGKVLKTGIIAAVTAFAANKHGRAVRCVLERGEDMLITGGRHPYLGKYKAGFMNDGRILALDMEHYSNAGASLDESLFVIEMGLLKMDNAYKFPNLRCRGWACRTNLPSNTAFRGFGFPQAALITESCITEVAAKCGLSPEKVRIINMYKEIDQTPYKQEINAKNLIQCWRECMAMSSYSLRKVAVEKFNAENYWKKKGLAMVPLKFPVGLGSRAAGQAAALVHIYLDGSVLVTHGGIEMGQGVHTKMIQVVSRELRMPMSNVHLRGTSTETVPNANISGGSVVADLNGLAVKDACQTLLKRLEPIISKNPKGTWKDWAQTAFDESINLSAVGYFRGYESDMNWEKGEGQPFEYFVYGAACSEVEIDCLTGDHKNIRTDIVMDVGCSINPAIDIGQIEGAFIQGMGLYTIEELNYSPQGILHTRGPDQYKIPAICDMPTELHIALLPPSQNSNTLYSSKGLGESGVFLGCSVFFAIHDAVSAARQERGLHGPLTLNSPLTPEKIRMACEDKFTKMIPRDEPGSYVPWNVPI", "pdbx_seq_one_letter_code_can": "MDRASELLFYVNGRKVIEKNVDPETMLLPYLRKKLRLTGTKYGCGGGGCGACTVMISRYNPITKRIRHHPANACLIPICSLYGAAVTTVEGIGSTHTRIHPVQERIAKCHGTQCGFCTPGMVMSIYTLLRNHPEPTLDQLTDALGGNLCRCTGYRPIIDACKTFCKTSGCCQSKENGVCCLDQGINGLPEFEEGSKTSPKLFAEEEFLPLDPTQELIFPPELMIMAEKQSQRTRVFGSERMMWFSPVTLKELLEFKFKYPQAPVIMGNTSVGPEVKFKGVFHPVIISPDRIEELSVVNHAYNGLTLGAGLSLAQVKDILADVVQKLPEEKTQMYHALLKHLGTLAGSQIRNMASLGGHIISRHPDSDLNPILAVGNCTLNLLSKEGKRQIPLNEQFLSKCPNADLKPQEILVSVNIPYSRKWEFVSAFRQAQRQENALAIVNSGMRVFFGEGDGIIRELCISYGGVGPATICAKNSCQKLIGRHWNEQMLDIACRLILNEVSLLGSAPGGKVEFKRTLIISFLFKFYLEVSQILKKMDPVHYPSLADKYESALEDLHSKHHCSTLKYQNIGPKQHPEDPIGHPIMHLSGVKHATGEAIYCDDMPLVDQELFLTFVTSSRAHAKIVSIDLSEALSMPGVVDIMTAEHLSDVNSFCFFTEAEKFLATDKVFCVGQLVCAVLADSEVQAKRAAKRVKIVYQDLEPLILTIEESIQHNSSFKPERKLEYGNVDEAFKVVDQILEGEIHMGGQEHFYMETQSMLVVPKGEDQEMDVYVSTQFPKYIQDIVASTLKLPANKVMCHVRRVGGAFGGKVLKTGIIAAVTAFAANKHGRAVRCVLERGEDMLITGGRHPYLGKYKAGFMNDGRILALDMEHYSNAGASLDESLFVIEMGLLKMDNAYKFPNLRCRGWACRTNLPSNTAFRGFGFPQAALITESCITEVAAKCGLSPEKVRIINMYKEIDQTPYKQEINAKNLIQCWRECMAMSSYSLRKVAVEKFNAENYWKKKGLAMVPLKFPVGLGSRAAGQAAALVHIYLDGSVLVTHGGIEMGQGVHTKMIQVVSRELRMPMSNVHLRGTSTETVPNANISGGSVVADLNGLAVKDACQTLLKRLEPIISKNPKGTWKDWAQTAFDESINLSAVGYFRGYESDMNWEKGEGQPFEYFVYGAACSEVEIDCLTGDHKNIRTDIVMDVGCSINPAIDIGQIEGAFIQGMGLYTIEELNYSPQGILHTRGPDQYKIPAICDMPTELHIALLPPSQNSNTLYSSKGLGESGVFLGCSVFFAIHDAVSAARQERGLHGPLTLNSPLTPEKIRMACEDKFTKMIPRDEPGSYVPWNVPI", "pdbx_strand_id": "A", "rcsb_artifact_monomer_count": 0, "rcsb_conflict_count": 0, "rcsb_deletion_count": 0, "rcsb_entity_polymer_type": "Protein", "rcsb_insertion_count": 0, "rcsb_mutation_count": 0, "rcsb_non_std_monomer_count": 0, "rcsb_sample_sequence_length": 1338, "type": "polypeptide(L)"}, "entity_src_gen": [{"gene_src_common_name": "HUMAN", "pdbx_alt_source_flag": "sample", "pdbx_gene_src_ncbi_taxonomy_id": "9606", "pdbx_gene_src_organ": "LIVER", "pdbx_gene_src_scientific_name": "HOMO SAPIENS", "pdbx_host_org_ncbi_taxonomy_id": "562", "pdbx_host_org_scientific_name": "ESCHERICHIA COLI", "pdbx_host_org_strain": "TP1000", "pdbx_src_id": 1}], "rcsb_cluster_flexibility": {"avg_rmsd": 0.277, "label": "No", "link": "http://pdbflex.org/cluster.html#!/6q6qA/37380/4uhxA", "max_rmsd": 0.331, "provenance_code": "PDBFlex"}, "rcsb_cluster_membership": [{"cluster_id": 21235, "identity": 100}, {"cluster_id": 14390, "identity": 95}, {"cluster_id": 15900, "identity": 90}, {"cluster_id": 12201, "identity": 70}, {"cluster_id": 1401, "identity": 50}, {"cluster_id": 1192, "identity": 30}], "rcsb_entity_host_organism": [{"ncbi_common_names": ["Bacillus coli", "Bacterium coli", "Bacterium coli commune", "E. coli", "Enterococcus coli", "Escherichia/Shigella coli"], "ncbi_parent_scientific_name": "Bacteria", "ncbi_scientific_name": "Escherichia coli", "ncbi_taxonomy_id": 562, "pdbx_src_id": 1, "provenance_source": "Primary Data", "scientific_name": "ESCHERICHIA COLI", "taxonomy_lineage": [{"depth": 1, "id": "131567", "name": "cellular organisms"}, {"depth": 1, "id": "131567", "name": "biota"}, {"depth": 2, "id": "2", "name": "Bacteria"}, {"depth": 2, "id": "2", "name": "Bacteria (ex Cavalier-Smith 1987)"}, {"depth": 2, "id": "2", "name": "Bacteria Woese et al. 2024"}, {"depth": 2, "id": "2", "name": "Bacteriobiota"}, {"depth": 2, "id": "2", "name": "bacteria"}, {"depth": 2, "id": "2", "name": "eubacteria"}, {"depth": 3, "id": "3379134", "name": "Pseudomonadati"}, {"depth": 4, "id": "1224", "name": "Pseudomonadota"}, {"depth": 4, "id": "1224", "name": "\"Alphaproteobacteriota\" Whitman et al. 2018"}, {"depth": 4, "id": "1224", "name": "Alphaproteobacteriota"}, {"depth": 4, "id": "1224", "name": "Proteobacteria"}, {"depth": 4, "id": "1224", "name": "Proteobacteriota"}, {"depth": 4, "id": "1224", "name": "proteobacteria"}, {"depth": 4, "id": "1224", "name": "purple photosynthetic bacteria and relatives"}, {"depth": 5, "id": "1236", "name": "Gammaproteobacteria"}, {"depth": 5, "id": "1236", "name": "Proteobacteria gamma subdivision"}, {"depth": 5, "id": "1236", "name": "Pseudomonadia"}, {"depth": 5, "id": "1236", "name": "Purple bacteria, gamma subdivision"}, {"depth": 5, "id": "1236", "name": "g-proteobacteria"}, {"depth": 5, "id": "1236", "name": "gamma proteobacteria"}, {"depth": 5, "id": "1236", "name": "gamma subdivision"}, {"depth": 5, "id": "1236", "name": "gamma subgroup"}, {"depth": 6, "id": "91347", "name": "Enterobacterales"}, {"depth": 6, "id": "91347", "name": "Enterobacteriaceae and related endosymbionts"}, {"depth": 6, "id": "91347", "name": "Enterobacteriaceae group"}, {"depth": 6, "id": "91347", "name": "Enterobacteriales"}, {"depth": 7, "id": "543", "name": "Enterobacteriaceae"}, {"depth": 7, "id": "543", "name": "Enterobacteraceae"}, {"depth": 7, "id": "543", "name": "enterobacteria"}, {"depth": 8, "id": "561", "name": "Escherichia"}, {"depth": 9, "id": "562", "name": "Escherichia coli"}, {"depth": 9, "id": "562", "name": "Bacillus coli"}, {"depth": 9, "id": "562", "name": "Bacterium coli"}, {"depth": 9, "id": "562", "name": "Bacterium coli commune"}, {"depth": 9, "id": "562", "name": "E. coli"}, {"depth": 9, "id": "562", "name": "Enterococcus coli"}, {"depth": 9, "id": "562", "name": "Escherichia/Shigella coli"}]}], "rcsb_entity_source_organism": [{"common_name": "HUMAN", "ncbi_common_names": ["human"], "ncbi_parent_scientific_name": "Eukaryota", "ncbi_scientific_name": "Homo sapiens", "ncbi_taxonomy_id": 9606, "pdbx_src_id": 1, "provenance_source": "Primary Data", "scientific_name": "HOMO SAPIENS", "source_type": "genetically engineered", "taxonomy_lineage": [{"depth": 1, "id": "131567", "name": "cellular organisms"}, {"depth": 1, "id": "131567", "name": "biota"}, {"depth": 2, "id": "2759", "name": "Eukaryota"}, {"depth": 2, "id": "2759", "name": "Eucarya"}, {"depth": 2, "id": "2759", "name": "Eucaryotae"}, {"depth": 2, "id": "2759", "name": "Eukarya"}, {"depth": 2, "id": "2759", "name": "Eukaryotae"}, {"depth": 2, "id": "2759", "name": "eukaryotes"}, {"depth": 3, "id": "33154", "name": "Opisthokonta"}, {"depth": 3, "id": "33154", "name": "Fungi/Metazoa group"}, {"depth": 3, "id": "33154", "name": "opisthokonts"}, {"depth": 4, "id": "33208", "name": "Metazoa"}, {"depth": 4, "id": "33208", "name": "Animalia"}, {"depth": 4, "id": "33208", "name": "animals"}, {"depth": 4, "id": "33208", "name": "metazoans"}, {"depth": 4, "id": "33208", "name": "multicellular animals"}, {"depth": 5, "id": "6072", "name": "Eumetazoa"}, {"depth": 6, "id": "33213", "name": "Bilateria"}, {"depth": 7, "id": "33511", "name": "Deuterostomia"}, {"depth": 7, "id": "33511", "name": "deuterostomes"}, {"depth": 8, "id": "7711", "name": "Chordata"}, {"depth": 8, "id": "7711", "name": "chordates"}, {"depth": 9, "id": "89593", "name": "Craniata"}, {"depth": 10, "id": "7742", "name": "Vertebrata"}, {"depth": 10, "id": "7742", "name": "vertebrates"}, {"depth": 11, "id": "7776", "name": "Gnathostomata"}, {"depth": 11, "id": "7776", "name": "jawed vertebrates"}, {"depth": 12, "id": "117570", "name": "Teleostomi"}, {"depth": 13, "id": "117571", "name": "Euteleostomi"}, {"depth": 13, "id": "117571", "name": "bony vertebrates"}, {"depth": 14, "id": "8287", "name": "Sarcopterygii"}, {"depth": 15, "id": "1338369", "name": "Dipnotetrapodomorpha"}, {"depth": 16, "id": "32523", "name": "Tetrapoda"}, {"depth": 16, "id": "32523", "name": "tetrapods"}, {"depth": 17, "id": "32524", "name": "Amniota"}, {"depth": 17, "id": "32524", "name": "amniotes"}, {"depth": 18, "id": "40674", "name": "Mammalia"}, {"depth": 18, "id": "40674", "name": "mammals"}, {"depth": 19, "id": "32525", "name": "Theria"}, {"depth": 20, "id": "9347", "name": "Eutheria"}, {"depth": 20, "id": "9347", "name": "Placentalia"}, {"depth": 20, "id": "9347", "name": "eutherian mammals"}, {"depth": 20, "id": "9347", "name": "placental mammals"}, {"depth": 20, "id": "9347", "name": "placentals"}, {"depth": 21, "id": "1437010", "name": "Boreoeutheria"}, {"depth": 21, "id": "1437010", "name": "Boreotheria"}, {"depth": 22, "id": "314146", "name": "Euarchontoglires"}, {"depth": 23, "id": "9443", "name": "Primates"}, {"depth": 23, "id": "9443", "name": "Primata"}, {"depth": 23, "id": "9443", "name": "primate"}, {"depth": 23, "id": "9443", "name": "primates"}, {"depth": 24, "id": "376913", "name": "Haplorrhini"}, {"depth": 25, "id": "314293", "name": "Simiiformes"}, {"depth": 25, "id": "314293", "name": "Anthropoidea"}, {"depth": 26, "id": "9526", "name": "Catarrhini"}, {"depth": 27, "id": "314295", "name": "Hominoidea"}, {"depth": 27, "id": "314295", "name": "ape"}, {"depth": 27, "id": "314295", "name": "apes"}, {"depth": 28, "id": "9604", "name": "Hominidae"}, {"depth": 28, "id": "9604", "name": "Pongidae"}, {"depth": 28, "id": "9604", "name": "great apes"}, {"depth": 29, "id": "207598", "name": "Homininae"}, {"depth": 29, "id": "207598", "name": "Homo/Pan/Gorilla group"}, {"depth": 30, "id": "9605", "name": "Homo"}, {"depth": 30, "id": "9605", "name": "humans"}, {"depth": 31, "id": "9606", "name": "Homo sapiens"}, {"depth": 31, "id": "9606", "name": "human"}]}], "rcsb_genomic_lineage": [{"depth": 0, "id": "9606", "name": "Homo sapiens"}, {"depth": 2, "id": "9606:2:aldehyde_oxidase_1", "name": "aldehyde oxidase 1"}, {"depth": 1, "id": "9606:2", "name": "Chromosome 2"}], "rcsb_polymer_entity": {"formula_weight": 148.096, "pdbx_description": "ALDEHYDE OXIDASE", "pdbx_ec": "1.2.3.1", "pdbx_number_of_molecules": 1, "rcsb_multiple_source_flag": "N", "rcsb_source_part_count": 1, "rcsb_source_taxonomy_count": 1, "src_method": "man", "rcsb_ec_lineage": [{"depth": 1, "id": "1", "name": "Oxidoreductases"}, {"depth": 2, "id": "1.2", "name": "Acting on the aldehyde or oxo group of donors"}, {"depth": 3, "id": "1.2.3", "name": "With oxygen as acceptor"}, {"depth": 4, "id": "1.2.3.1", "name": "aldehyde oxidase"}, {"depth": 1, "id": "1", "name": "Oxidoreductases"}, {"depth": 2, "id": "1.17", "name": "Acting on CH or CH2 groups"}, {"depth": 3, "id": "1.17.3", "name": "With oxygen as acceptor"}], "rcsb_macromolecular_names_combined": [{"name": "ALDEHYDE OXIDASE", "provenance_code": "ECO:0000304", "provenance_source": "PDB Preferred Name"}, {"name": "ALDEHYDE OXIDASE 1", "provenance_code": "ECO:0000303", "provenance_source": "PDB Synonym"}, {"name": "AZAHETEROCYCLE HYDROXYLASE", "provenance_code": "ECO:0000303", "provenance_source": "PDB Synonym"}], "rcsb_enzyme_class_combined": [{"depth": 4, "ec": "1.2.3.1", "provenance_source": "PDB Primary Data"}, {"depth": 3, "ec": "1.17.3", "provenance_source": "UniProt"}], "rcsb_polymer_name_combined": {"names": ["Aldehyde oxidase"], "provenance_source": "UniProt Name"}}, "rcsb_polymer_entity_align": [{"provenance_source": "SIFTS", "reference_database_accession": "Q06278", "reference_database_name": "UniProt", "aligned_regions": [{"entity_beg_seq_id": 1, "length": 1338, "ref_beg_seq_id": 1}]}], "rcsb_polymer_entity_annotation": [{"annotation_id": "PF20256", "assignment_version": "34.0", "name": "Molybdopterin cofactor-binding domain (MoCoBD_2)", "provenance_source": "Pfam", "type": "Pfam"}, {"annotation_id": "PF00111", "assignment_version": "34.0", "name": "2Fe-2S iron-sulfur cluster binding domain (Fer2)", "provenance_source": "Pfam", "type": "Pfam"}, {"annotation_id": "PF00941", "assignment_version": "34.0", "name": "FAD binding domain in molybdopterin dehydrogenase (FAD_binding_5)", "provenance_source": "Pfam", "type": "Pfam"}, {"annotation_id": "PF03450", "assignment_version": "34.0", "name": "CO dehydrogenase flavoprotein C-terminal domain (CO_deh_flav_C)", "provenance_source": "Pfam", "type": "Pfam"}, {"annotation_id": "PF01799", "assignment_version": "34.0", "name": "[2Fe-2S] binding domain (Fer2_2)", "provenance_source": "Pfam", "type": "Pfam"}, {"annotation_id": "PF01315", "assignment_version": "34.0", "name": "Aldehyde oxidase and xanthine dehydrogenase, a/b hammerhead domain (Ald_Xan_dh_C)", "provenance_source": "Pfam", "type": "Pfam"}, {"annotation_id": "PF02738", "assignment_version": "34.0", "name": "Molybdopterin cofactor-binding domain (MoCoBD_1)", "provenance_source": "Pfam", "type": "Pfam"}, {"annotation_id": "IPR016167", "name": "FAD-binding, type PCMH, subdomain 1", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR016167", "name": "FAD-binding, type PCMH, subdomain 1"}]}, {"annotation_id": "IPR001041", "name": "2Fe-2S ferredoxin-type iron-sulfur binding domain", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 1, "id": "IPR001041", "name": "2Fe-2S ferredoxin-type iron-sulfur binding domain"}]}, {"annotation_id": "GO:0071949", "name": "FAD binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0071949", "name": "FAD binding"}, {"id": "GO:0050660", "name": "flavin adenine dinucleotide binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:1901265", "name": "nucleoside phosphate binding"}, {"id": "GO:0043167", "name": "ion binding"}, {"id": "GO:0043168", "name": "anion binding"}, {"id": "GO:0000166", "name": "nucleotide binding"}, {"id": "GO:1901363", "name": "heterocyclic compound binding"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0036094", "name": "small molecule binding"}]}, {"annotation_id": "GO:0070062", "name": "extracellular exosome", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0070062", "name": "extracellular exosome"}, {"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:1903561", "name": "extracellular vesicle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0043230", "name": "extracellular organelle"}, {"id": "GO:0005576", "name": "extracellular region"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0005615", "name": "extracellular space"}, {"id": "GO:0031982", "name": "vesicle"}, {"id": "GO:0065010", "name": "extracellular membrane-bounded organelle"}]}, {"annotation_id": "IPR006058", "name": "2Fe-2S ferredoxin, iron-sulphur binding site", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR006058", "name": "2Fe-2S ferredoxin, iron-sulphur binding site"}]}, {"annotation_id": "GO:0050660", "name": "flavin adenine dinucleotide binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0050660", "name": "flavin adenine dinucleotide binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:1901265", "name": "nucleoside phosphate binding"}, {"id": "GO:0043167", "name": "ion binding"}, {"id": "GO:0043168", "name": "anion binding"}, {"id": "GO:0000166", "name": "nucleotide binding"}, {"id": "GO:1901363", "name": "heterocyclic compound binding"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0036094", "name": "small molecule binding"}]}, {"annotation_id": "GO:0005829", "name": "cytosol", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0005737", "name": "cytoplasm"}, {"id": "GO:0005829", "name": "cytosol"}]}, {"annotation_id": "IPR046867", "name": "Aldehyde oxidase/xanthine dehydrogenase, second molybdopterin binding domain", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR046867", "name": "Aldehyde oxidase/xanthine dehydrogenase, second molybdopterin binding domain"}]}, {"annotation_id": "GO:0004031", "name": "aldehyde oxidase activity", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0016491", "name": "oxidoreductase activity"}, {"id": "GO:0004031", "name": "aldehyde oxidase activity"}, {"id": "GO:0016903", "name": "oxidoreductase activity, acting on the aldehyde or oxo group of donors"}, {"id": "GO:0003824", "name": "catalytic activity"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0016623", "name": "oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor"}]}, {"annotation_id": "IPR002888", "name": "[2Fe-2S]-binding", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR002888", "name": "[2Fe-2S]-binding"}]}, {"annotation_id": "GO:0006629", "name": "lipid metabolic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0044238", "name": "primary metabolic process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0006629", "name": "lipid metabolic process"}]}, {"annotation_id": "IPR036318", "name": "FAD-binding, type PCMH-like superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR036318", "name": "FAD-binding, type PCMH-like superfamily"}]}, {"annotation_id": "IPR016208", "name": "Aldehyde oxidase/xanthine dehydrogenase-like", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 1, "id": "IPR016208", "name": "Aldehyde oxidase/xanthine dehydrogenase-like"}]}, {"annotation_id": "IPR012675", "name": "Beta-grasp domain superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR012675", "name": "Beta-grasp domain superfamily"}]}, {"annotation_id": "GO:0015630", "name": "microtubule cytoskeleton", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0005856", "name": "cytoskeleton"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0043228", "name": "membraneless organelle"}, {"id": "GO:0043232", "name": "intracellular membraneless organelle"}, {"id": "GO:0015630", "name": "microtubule cytoskeleton"}]}, {"annotation_id": "GO:0045171", "name": "intercellular bridge", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0045171", "name": "intercellular bridge"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005575", "name": "cellular_component"}]}, {"annotation_id": "IPR036683", "name": "CO dehydrogenase flavoprotein, C-terminal domain superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR036683", "name": "CO dehydrogenase flavoprotein, C-terminal domain superfamily"}]}, {"annotation_id": "IPR036010", "name": "2Fe-2S ferredoxin-like superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR036010", "name": "2Fe-2S ferredoxin-like superfamily"}]}, {"annotation_id": "IPR000674", "name": "Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR000674", "name": "Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead"}]}, {"annotation_id": "GO:0042803", "name": "protein homodimerization activity", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0042802", "name": "identical protein binding"}, {"id": "GO:0005515", "name": "protein binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:0042803", "name": "protein homodimerization activity"}, {"id": "GO:0046983", "name": "protein dimerization activity"}, {"id": "GO:0003674", "name": "molecular_function"}]}, {"annotation_id": "GO:0006805", "name": "xenobiotic metabolic process", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0051716", "name": "cellular response to stimulus"}, {"id": "GO:0070887", "name": "cellular response to chemical stimulus"}, {"id": "GO:0050896", "name": "response to stimulus"}, {"id": "GO:0042221", "name": "response to chemical"}, {"id": "GO:0071466", "name": "cellular response to xenobiotic stimulus"}, {"id": "GO:0008150", "name": "biological_process"}, {"id": "GO:0008152", "name": "metabolic process"}, {"id": "GO:0009987", "name": "cellular process"}, {"id": "GO:0006805", "name": "xenobiotic metabolic process"}, {"id": "GO:0009410", "name": "response to xenobiotic stimulus"}]}, {"annotation_id": "IPR022407", "name": "Oxidoreductase, molybdopterin binding site", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR022407", "name": "Oxidoreductase, molybdopterin binding site"}]}, {"annotation_id": "GO:0051537", "name": "2 iron, 2 sulfur cluster binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0051536", "name": "iron-sulfur cluster binding"}, {"id": "GO:0051537", "name": "2 iron, 2 sulfur cluster binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:0051540", "name": "metal cluster binding"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0036094", "name": "small molecule binding"}]}, {"annotation_id": "GO:0005506", "name": "iron ion binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043169", "name": "cation binding"}, {"id": "GO:0046914", "name": "transition metal ion binding"}, {"id": "GO:0005506", "name": "iron ion binding"}, {"id": "GO:0043167", "name": "ion binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0046872", "name": "metal ion binding"}, {"id": "GO:0036094", "name": "small molecule binding"}]}, {"annotation_id": "IPR036856", "name": "Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR036856", "name": "Aldehyde oxidase/xanthine dehydrogenase, a/b hammerhead superfamily"}]}, {"annotation_id": "IPR014313", "name": "Aldehyde oxidase", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 2, "id": "IPR014313", "name": "Aldehyde oxidase"}, {"depth": 1, "id": "IPR016208", "name": "Aldehyde oxidase/xanthine dehydrogenase-like"}]}, {"annotation_id": "IPR037165", "name": "Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding domain superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR037165", "name": "Aldehyde oxidase/xanthine dehydrogenase, molybdopterin binding domain superfamily"}]}, {"annotation_id": "IPR016166", "name": "FAD-binding domain, PCMH-type", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 1, "id": "IPR016166", "name": "FAD-binding domain, PCMH-type"}]}, {"annotation_id": "IPR002346", "name": "Molybdopterin dehydrogenase, FAD-binding", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"depth": 1, "id": "IPR016166", "name": "FAD-binding domain, PCMH-type"}, {"depth": 2, "id": "IPR002346", "name": "Molybdopterin dehydrogenase, FAD-binding"}]}, {"annotation_id": "GO:0043546", "name": "molybdopterin cofactor binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0005488", "name": "binding"}, {"id": "GO:0043546", "name": "molybdopterin cofactor binding"}, {"id": "GO:0003674", "name": "molecular_function"}]}, {"annotation_id": "GO:0051287", "name": "NAD binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0051287", "name": "NAD binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:1901265", "name": "nucleoside phosphate binding"}, {"id": "GO:0017076", "name": "purine nucleotide binding"}, {"id": "GO:0030554", "name": "adenyl nucleotide binding"}, {"id": "GO:0000166", "name": "nucleotide binding"}, {"id": "GO:1901363", "name": "heterocyclic compound binding"}, {"id": "GO:0003674", "name": "molecular_function"}, {"id": "GO:0036094", "name": "small molecule binding"}]}, {"annotation_id": "IPR016169", "name": "FAD-binding, type PCMH, subdomain 2", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR016169", "name": "FAD-binding, type PCMH, subdomain 2"}]}, {"annotation_id": "GO:0016604", "name": "nuclear body", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0043227", "name": "membrane-bounded organelle"}, {"id": "GO:0005575", "name": "cellular_component"}, {"id": "GO:0005622", "name": "intracellular anatomical structure"}, {"id": "GO:0005634", "name": "nucleus"}, {"id": "GO:0031974", "name": "membrane-enclosed lumen"}, {"id": "GO:0043232", "name": "intracellular membraneless organelle"}, {"id": "GO:0043231", "name": "intracellular membrane-bounded organelle"}, {"id": "GO:0070013", "name": "intracellular organelle lumen"}, {"id": "GO:0016604", "name": "nuclear body"}, {"id": "GO:0043229", "name": "intracellular organelle"}, {"id": "GO:0110165", "name": "cellular anatomical structure"}, {"id": "GO:0005654", "name": "nucleoplasm"}, {"id": "GO:0043233", "name": "organelle lumen"}, {"id": "GO:0043226", "name": "organelle"}, {"id": "GO:0043228", "name": "membraneless organelle"}, {"id": "GO:0031981", "name": "nuclear lumen"}]}, {"annotation_id": "IPR036884", "name": "[2Fe-2S]-binding domain superfamily", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR036884", "name": "[2Fe-2S]-binding domain superfamily"}]}, {"annotation_id": "GO:0042802", "name": "identical protein binding", "provenance_source": "UNIPROT", "type": "GO", "annotation_lineage": [{"id": "GO:0042802", "name": "identical protein binding"}, {"id": "GO:0005515", "name": "protein binding"}, {"id": "GO:0005488", "name": "binding"}, {"id": "GO:0003674", "name": "molecular_function"}]}, {"annotation_id": "IPR008274", "name": "Aldehyde oxidase/xanthine dehydrogenase, first molybdopterin binding domain", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR008274", "name": "Aldehyde oxidase/xanthine dehydrogenase, first molybdopterin binding domain"}]}, {"annotation_id": "IPR005107", "name": "CO dehydrogenase flavoprotein, C-terminal", "provenance_source": "UNIPROT", "type": "InterPro", "annotation_lineage": [{"id": "IPR005107", "name": "CO dehydrogenase flavoprotein, C-terminal"}]}], "rcsb_polymer_entity_container_identifiers": {"asym_ids": ["A"], "auth_asym_ids": ["A"], "chem_comp_monomers": ["ALA", "ARG", "ASN", "ASP", "CYS", "GLN", "GLU", "GLY", "HIS", "ILE", "LEU", "LYS", "MET", "PHE", "PRO", "SER", "THR", "TRP", "TYR", "VAL"], "entity_id": "1", "entry_id": "4UHX", "rcsb_id": "4UHX_1", "uniprot_ids": ["Q06278"], "reference_sequence_identifiers": [{"database_accession": "Q06278", "database_name": "UniProt", "entity_sequence_coverage": 1.0, "provenance_source": "SIFTS", "reference_sequence_coverage": 1.0}]}, "rcsb_polymer_entity_feature": [{"assignment_version": "34.0", "feature_id": "PF03450", "name": "CO dehydrogenase flavoprotein C-terminal domain (CO_deh_flav_C)", "provenance_source": "Pfam", "type": "Pfam", "feature_positions": [{"beg_seq_id": 426, "end_seq_id": 530}]}, {"assignment_version": "34.0", "feature_id": "PF00941", "name": "FAD binding domain in molybdopterin dehydrogenase (FAD_binding_5)", "provenance_source": "Pfam", "type": "Pfam", "feature_positions": [{"beg_seq_id": 236, "end_seq_id": 419}]}, {"assignment_version": "34.0", "feature_id": "PF01799", "name": "[2Fe-2S] binding domain (Fer2_2)", "provenance_source": "Pfam", "type": "Pfam", "feature_positions": [{"beg_seq_id": 88, "end_seq_id": 162}]}, {"assignment_version": "34.0", "feature_id": "PF01315", "name": "Aldehyde oxidase and xanthine dehydrogenase, a/b hammerhead domain (Ald_Xan_dh_C)", "provenance_source": "Pfam", "type": "Pfam", "feature_positions": [{"beg_seq_id": 594, "end_seq_id": 701}]}, {"assignment_version": "34.0", "feature_id": "PF00111", "name": "2Fe-2S iron-sulfur cluster binding domain (Fer2)", "provenance_source": "Pfam", "type": "Pfam", "feature_positions": [{"beg_seq_id": 9, "end_seq_id": 79}]}, {"assignment_version": "34.0", "feature_id": "PF02738", "name": "Molybdopterin cofactor-binding domain (MoCoBD_1)", "provenance_source": "Pfam", "type": "Pfam", "feature_positions": [{"beg_seq_id": 707, "end_seq_id": 955}]}, {"assignment_version": "34.0", "feature_id": "PF20256", "name": "Molybdopterin cofactor-binding domain (MoCoBD_2)", "provenance_source": "Pfam", "type": "Pfam", "feature_positions": [{"beg_seq_id": 979, "end_seq_id": 1245}]}, {"name": "Hydropathy values", "provenance_source": "biojava-7.2.4", "type": "hydropathy", "feature_positions": [{"beg_seq_id": 5, "values": [0.2, -0.16, 0.7, 0.81, 0.57, 0.16, 0.11, 0.16, 0.23, -0.47, -0.76, -1.61, -0.76, -1.1, -0.78, -0.73, -1.28, -1.57, -0.76, 0.1, 0.31, -0.3, 0.51, 0.19, 0.14, -0.21, 0.0, -0.92, -0.92, -0.82, -0.72, -1.22, -1.16, -0.87, -0.48, -0.62, -0.17, -0.63, -0.6, -0.6, -0.24, 0.14, 0.49, 0.81, 0.46, 0.97, 1.22, 1.77, 1.72, 0.94, 0.84, 0.26, -0.2, 0.38, -0.17, -0.81, -1.81, -1.22, -1.22, -1.43, -1.4, -1.4, -1.7, -2.01, -1.38, -0.6, -0.68, 0.32, 0.5, 1.36, 1.81, 1.52, 2.33, 1.99, 1.67, 1.44, 1.14, 1.79, 1.21, 0.86, 1.41, 0.6, 0.7, 1.24, 1.0, 0.71, 0.17, -0.11, -0.11, -1.08, -0.19, -0.5, -1.18, -0.67, -0.97, -1.28, -1.42, -0.84, -0.14, -1.08, -0.44, -0.62, -1.13, -0.82, -0.82, -0.04, -0.59, -0.48, 0.23, -0.12, 0.06, 0.06, 0.34, 1.2, 1.13, 1.09, 1.28, 0.86, 0.86, 1.46, 1.92, 1.21, 0.36, -0.21, -0.3, -1.19, -1.22, -1.22, -1.22, -2.03, -1.92, -1.11, -0.83, -1.04, -0.46, 0.14, 0.18, -0.29, -0.29, 0.52, 0.38, -0.04, 0.62, 0.34, -0.12, -0.22, -0.68, -0.47, -0.39, -0.17, -0.06, -0.13, 0.22, -0.17, -0.1, 0.71, 1.17, 0.23, -0.34, -0.04, -0.29, -0.29, 0.42, 0.11, -0.29, -1.0, -0.96, -1.27, -1.22, -0.71, -0.71, -0.71, 0.1, -0.2, -0.16, 0.19, 1.08, 0.73, 0.22, 0.37, -0.09, -0.9, -0.2, -0.2, -0.54, -1.09, -0.79, -1.18, -1.68, -1.59, -1.38, -2.12, -1.31, -0.61, -0.37, -0.67, -0.62, -0.93, -0.53, 0.07, 0.32, 0.32, -0.38, -0.76, -0.44, -0.44, -0.44, -0.33, -0.26, 0.23, -0.37, -0.16, -0.37, 0.13, 0.73, 1.62, 1.41, 1.11, 0.41, 0.16, -0.06, 0.24, -0.57, -1.28, -1.86, -2.57, -2.3, -1.6, -1.21, -0.91, -1.21, -1.32, -0.61, -0.32, 0.08, -0.08, -0.48, -0.61, -0.06, 0.26, 1.18, 0.53, -0.07, 0.46, 0.57, 0.27, 0.76, -0.14, 0.24, -0.61, -0.32, -0.11, -0.92, -1.14, -0.93, -0.78, 0.16, 0.06, 0.44, 0.2, 0.3, 0.6, 0.87, 1.0, 0.36, -0.53, -0.28, -0.67, 0.03, -0.32, -0.28, -0.28, 0.08, -0.1, 0.11, 0.11, 1.04, 1.23, 1.58, 1.44, 0.59, -0.22, 0.63, 0.42, -0.43, -0.51, -1.1, -0.54, 0.1, 0.1, 0.24, -0.06, 0.19, 0.19, -0.28, 0.23, -0.31, -0.36, -0.01, 0.54, 0.3, 0.87, 1.17, 1.63, 1.41, 1.1, 1.14, 0.76, 0.17, 0.71, 0.71, 1.0, 0.19, 0.46, 1.31, 0.46, 0.46, 1.27, 0.59, -0.22, -0.81, -0.86, -1.4, -2.26, -1.66, -1.37, -2.14, -1.77, -0.96, -0.14, -0.14, -0.42, 0.39, 0.13, 0.2, 0.98, 0.98, 0.51, 0.0, 0.04, 0.9, -0.02, -0.37, -0.08, -0.3, -0.59, -0.12, -0.08, 0.27, -0.59, 0.41, 1.3, 1.0, 0.3, 0.03, -0.57, -0.91, -0.96, -0.99, -1.07, -1.96, -2.04, -1.04, -0.27, 0.11, 0.97, 1.01, 1.01, 0.87, 1.18, 1.78, 0.89, 0.89, 1.11, 0.56, 0.17, 0.17, -0.16, -0.51, -1.43, -1.43, -1.36, -1.96, -1.44, -1.4, -1.4, -1.74, -1.0, -0.08, 0.22, -0.71, -0.26, -0.86, -0.86, -0.27, -0.27, -0.16, -1.01, -1.1, -1.06, -1.72, -1.04, -0.23, 0.03, 0.33, 0.38, 0.42, 1.1, 1.31, 1.56, 0.97, 0.04, -0.86, -0.87, -1.72, -1.02, -1.06, -0.97, -0.62, -0.22, -0.22, -0.18, 0.12, 0.12, -0.69, -1.54, -1.84, -2.43, -2.54, -1.62, -1.03, -0.73, 0.12, 0.23, 0.53, 0.88, 1.48, 0.78, 0.82, 0.93, 0.74, 0.23, 0.23, 0.28, -0.07, -0.32, 0.68, 0.71, -0.1, -0.8, -0.33, 0.33, 0.88, 1.18, 1.08, 0.53, -0.01, 0.96, 1.3, 0.7, 0.62, 0.04, 0.63, 1.06, 1.3, 0.91, 0.06, 0.01, 0.47, -0.12, -0.48, -0.56, -0.33, -0.58, -0.64, -0.61, -0.62, -1.29, -1.29, -1.24, -1.46, -1.53, -1.88, -0.88, -0.32, 0.06, -0.06, 0.76, 1.64, 1.86, 1.04, 1.04, 1.01, 0.72, 0.87, 1.79, 1.32, 0.73, 0.51, 0.72, 1.07, 0.56, 0.21, 0.26, -0.56, -0.2, -0.54, -1.24, -1.14, -0.68, -0.13, 0.8, 0.24, 0.94, 1.06, 1.8, 1.87, 2.26, 1.69, 1.61, 0.72, 1.28, 0.88, 0.07, 0.26, 1.11, 0.37, 0.08, -0.13, -0.13, -0.78, -0.22, -0.19, -0.83, -1.43, -1.09, -0.23, -0.24, -0.24, -0.5, -1.11, -1.14, -1.09, -0.71, -0.2, -1.01, -1.6, -0.79, -0.71, -0.66, -0.7, -0.97, -1.52, -1.67, -1.37, -1.06, -1.06, -1.13, -1.19, -1.14, -1.18, -0.32, -0.64, -0.73, -1.09, -1.9, -1.82, -1.86, -1.86, -1.86, -2.53, -1.99, -1.86, -1.78, -1.57, -0.71, -0.32, -0.29, 0.52, 0.61, 0.07, 0.58, 0.5, 0.32, 0.02, -0.27, 0.04, -0.77, -0.48, 0.07, -0.54, 0.17, 0.13, -0.46, -0.17, -0.3, 0.51, 0.78, -0.11, -0.36, -1.02, -0.21, 0.49, 0.7, 0.8, 0.69, 0.69, 1.0, 1.3, 1.6, 0.68, 0.57, -0.21, 0.07, -0.68, -0.64, -0.1, -0.1, 0.49, 0.6, 0.82, 1.09, 0.5, 1.13, 1.06, 0.5, 0.8, 0.12, 0.47, 0.51, 1.07, 1.07, 1.37, 1.16, 1.17, 1.16, 0.94, 0.63, 0.59, 0.03, 0.03, 0.0, -0.6, -0.61, -0.5, 0.17, 0.83, 0.72, 0.73, 0.73, 0.47, 0.47, 0.12, 0.12, 0.27, 0.16, -0.23, -0.54, -0.59, -0.32, 0.38, 1.09, 1.24, 0.78, 0.19, 0.69, 1.54, 2.26, 1.99, 2.14, 2.29, 2.02, 1.68, 1.98, 1.17, 1.17, 0.5, 0.5, -0.4, -1.32, -1.32, -0.73, -1.08, -1.19, -1.19, -1.23, -0.93, -0.03, 0.32, -0.27, -0.86, 0.0, 0.11, -0.53, 0.32, 0.32, 0.28, 0.34, 1.23, 1.23, 0.42, 0.72, 1.4, 0.59, -0.27, -1.08, -1.09, -1.68, -0.98, -1.02, -1.11, -2.0, -2.11, -2.19, -1.38, -1.68, -1.73, -2.09, -2.04, -1.4, -1.4, -1.29, -0.66, -0.77, -0.81, -0.2, 0.31, 0.31, -0.54, 0.34, 1.16, 0.57, 0.21, 0.26, 0.29, -0.53, 0.07, 0.41, -0.13, -0.94, -0.94, -1.26, -0.56, -1.2, -0.63, -1.23, -1.27, -1.61, -1.31, -0.71, 0.07, 0.22, 0.83, 0.44, 0.4, 0.43, 0.43, 0.13, -0.47, -1.28, -1.53, -2.39, -1.74, -1.46, -0.94, -0.64, -0.33, -0.33, 0.37, -0.02, -0.07, -0.68, -0.03, -0.89, -1.19, -0.61, 0.24, 0.13, 0.22, 0.58, 1.14, 0.21, 1.02, 1.23, 0.93, 0.08, -0.56, 0.0, 0.29, 0.14, 0.22, 0.27, -0.06, -0.76, 0.1, 0.49, -0.02, -0.03, 0.0, 0.31, -0.2, -0.13, 0.83, 0.79, 0.4, 0.37, 0.12, 0.31, 0.86, 1.1, 1.73, 1.73, 1.23, 1.87, 2.26, 2.5, 2.2, 1.31, 0.68, 0.12, -0.39, -0.81, -0.81, -0.66, -1.36, -1.28, -0.42, 0.43, 0.4, -0.06, 0.4, -0.19, -1.04, -0.33, -0.19, -0.16, -0.66, -0.31, 0.14, -0.31, -0.28, -0.07, -0.42, -0.42, -0.97, -1.32, -1.42, -1.81, -1.11, -0.8, -0.31, 0.04, -0.77, -1.11, -0.72, -1.08, -0.14, 0.08, 0.32, 0.43, -0.17, 0.43, 0.43, 0.12, 0.48, -0.11, -0.92, -0.92, -1.39, -0.8, -1.1, -0.29, -0.32, -0.57, -0.57, 0.24, 0.36, 0.87, 1.17, 0.87, 0.66, 1.0, 1.81, 2.32, 1.47, 1.37, 0.51, -0.38, 0.21, -0.14, -0.53, -0.64, -1.24, -1.2, -0.99, -1.1, -0.43, -1.13, -1.03, -0.7, -0.81, -0.36, -0.47, -0.97, -0.86, -0.71, -0.39, -0.43, -0.72, -1.0, -1.08, -0.27, -0.69, -0.34, -0.46, -0.32, 0.08, 0.29, -0.02, -0.02, -0.13, 0.79, 1.33, 0.94, 0.6, 0.2, 0.66, 1.54, 1.27, 0.68, 0.72, 0.42, 0.7, 0.66, 1.02, 0.7, 0.62, 0.61, 0.82, -0.03, -0.67, -0.4, -0.47, -0.24, 0.3, -0.51, -0.21, -0.18, -0.22, -0.18, -0.14, -0.03, -0.92, -1.5, -1.29, -1.64, -1.93, -1.89, -1.89, -1.89, -1.89, -1.3, -1.66, -1.87, -1.3, -0.37, -0.37, 0.3, -0.3, -0.41, -1.0, -0.29, 0.31, 0.09, -0.2, 0.1, -0.27, -0.31, 0.1, 0.91, 0.13, -0.51, -0.24, -0.26, 0.3, 0.0, -0.29, 0.11, -0.7, 0.0, 0.04, -0.81, -1.16, -1.72, -1.77, -1.77, -2.51, -2.17, -1.94, -1.36, -0.76, -0.14, -0.22, 0.63, 0.63, 1.38, 1.24, 1.29, 1.04, 1.26, 0.74, 0.83, -0.09, 0.54, 0.43, 0.57, -0.29, -0.04, -0.27, -0.02, 0.49, 1.46, 0.9, 1.2, 1.1, 1.91, 1.32, 1.08, 0.79, 0.83, 0.79, 1.61, 1.03, 0.82, 0.36, 0.7, 1.24, 0.94, 0.69, 0.22, -0.63, -0.6, 0.22, -0.09, -0.12, -1.06, -0.46, -0.17, -0.51, 0.34, 0.86, 0.3, 0.16, -0.16, 0.7, -0.01, -0.3, -0.09, -0.34, -0.9, -1.2, -0.23, -0.2, -0.2, -0.2, -0.46, -0.36, -0.66, -0.64, -0.64, -1.19, -0.37, -0.97, -0.86, -0.61, -0.92, -0.33, -0.34, 0.0, 0.03, -0.52, 0.12, 0.98, 0.98, 0.98, 0.9, 0.6, 0.6, 1.07, 1.36, 1.36, 0.46, -0.13, 0.46, 0.31, 0.31, 0.28, 0.28, 0.5, -0.4, -0.47, 0.34, -0.24, -0.7, 0.19, 0.77, 0.26, -0.6, -0.56, -0.23, -1.09, -0.74, -0.64, -1.24, -2.18, -2.48, -2.14, -1.56, -1.77, -1.41, -1.17, -0.78, -1.07, -1.02, -0.72, -0.12, -0.71, 0.1, 0.09, 0.09, 0.24, 0.59, 0.83, 1.23, 0.23, 0.58, 0.01, -0.29, -0.58, -1.43, -1.18, -1.42, -1.83, -1.72, -2.11, -2.01, -2.01, -1.97, -1.97, -2.36, -1.66, -1.94, -1.7, -0.96, -0.44, -0.2, -0.2, 0.39, 0.77, 0.73, 1.03, 0.79, 0.94, 0.09, 0.73, 0.39, 0.47, 0.69, 0.33, 0.38, 0.38, -0.44, -0.49, -1.38, -0.49, -1.27, -1.77, -2.08, -1.53, -0.68, -0.11, -0.07, 0.79, 0.24, 1.02, 1.01, 1.9, 1.01, 0.37, 0.36, 1.24, 0.39, 0.93, 0.61, 0.31, 0.31, 0.31, 0.44, 0.44, 0.26, 1.14, 0.26, 0.26, 0.86, 0.31, 1.12, 1.02, 0.74, 0.93, 0.04, 0.04, 0.51, -0.09, -0.19, -0.7, -0.73, -1.04, -1.59, -0.7, 0.11, -0.67, -0.36, -0.71, -0.67, -0.67, -0.67, -1.01, -1.66, -2.51, -1.66, -1.76, -1.06, -0.51, -0.06, -0.06, 0.54, 0.51, 0.87, -0.02, 0.58, 0.02, 0.02, -0.06, 0.76, 0.97, 0.97, 0.87, 1.17, 0.36, 0.32, -0.27, -0.86, -1.36, -1.36, -1.32, -1.23, -1.23, -1.28, -0.93, -0.42, -0.08, -0.39, -0.9, -0.8, -0.24, 0.16, 1.01, 1.01, 0.87, 0.82, 1.68, 2.08, 2.43, 2.17, 2.36, 1.58, 1.23, 1.16, 1.71, 1.16, 1.04, 0.93, 0.23, -0.66, -0.69, -0.8, -1.04, -1.09, -1.36, -1.6, -1.98, -1.06, -0.74, 0.07, 0.18, 0.13, -0.47, 0.31, 0.28, 0.28, -0.53, -0.89, -0.81, -0.92, -0.62, -0.24, -0.39, -0.7, -0.91, -0.96, -0.21, -0.79, -0.72, -0.72, -0.42, -0.88, -0.99, -0.99, -0.94, -1.43, -1.4, -1.06, -1.41, -1.44, -1.44, -1.04, -1.04, -0.19, -0.19, 0.36]}]}, {"name": "Disordered binding sites", "provenance_source": "Anchor2", "type": "disorder_binding", "feature_positions": [{"beg_seq_id": 1, "values": [0.39, 0.38, 0.38, 0.37, 0.37, 0.36, 0.33, 0.31, 0.32, 0.35, 0.39, 0.43, 0.39, 0.36, 0.32, 0.3, 0.27, 0.24, 0.23, 0.22, 0.24, 0.26, 0.29, 0.32, 0.36, 0.41, 0.41, 0.38, 0.36, 0.35, 0.34, 0.35, 0.38, 0.42, 0.4, 0.33, 0.26, 0.2, 0.14, 0.1, 0.07, 0.04, 0.03, 0.02, 0.02, 0.01, 0.01, 0.01, 0.01, 0.02, 0.02, 0.03, 0.04, 0.06, 0.1, 0.13, 0.16, 0.2, 0.24, 0.27, 0.29, 0.31, 0.32, 0.27, 0.24, 0.22, 0.2, 0.18, 0.13, 0.1, 0.08, 0.06, 0.05, 0.04, 0.04, 0.04, 0.04, 0.04, 0.04, 0.05, 0.06, 0.08, 0.09, 0.11, 0.14, 0.15, 0.16, 0.18, 0.21, 0.24, 0.24, 0.26, 0.27, 0.29, 0.3, 0.33, 0.35, 0.38, 0.37, 0.35, 0.32, 0.3, 0.27, 0.22, 0.17, 0.14, 0.1, 0.07, 0.05, 0.04, 0.04, 0.03, 0.03, 0.03, 0.04, 0.05, 0.06, 0.09, 0.13, 0.2, 0.26, 0.32, 0.38, 0.42, 0.4, 0.39, 0.39, 0.38, 0.42, 0.4, 0.34, 0.3, 0.26, 0.24, 0.23, 0.22, 0.21, 0.2, 0.15, 0.12, 0.08, 0.05, 0.03, 0.02, 0.01, 0.01, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.01, 0.01, 0.02, 0.02, 0.02, 0.02, 0.02, 0.01, 0.01, 0.01, 0.01, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.01, 0.01, 0.01, 0.01, 0.01, 0.02, 0.03, 0.05, 0.07, 0.1, 0.14, 0.17, 0.21, 0.26, 0.3, 0.34, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.39, 0.41, 0.43, 0.4, 0.37, 0.35, 0.33, 0.33, 0.32, 0.31, 0.3, 0.3, 0.31, 0.32, 0.34, 0.35, 0.36, 0.36, 0.35, 0.35, 0.34, 0.35, 0.35, 0.35, 0.35, 0.35, 0.35, 0.36, 0.38, 0.4, 0.43, 0.41, 0.4, 0.38, 0.37, 0.36, 0.36, 0.37, 0.38, 0.39, 0.4, 0.41, 0.42, 0.43, 0.43, 0.42, 0.43, 0.43, 0.41, 0.4, 0.38, 0.38, 0.37, 0.35, 0.34, 0.33, 0.31, 0.29, 0.28, 0.27, 0.26, 0.25, 0.24, 0.23, 0.23, 0.23, 0.23, 0.23, 0.23, 0.24, 0.24, 0.23, 0.23, 0.22, 0.21, 0.2, 0.2, 0.19, 0.18, 0.17, 0.16, 0.16, 0.16, 0.16, 0.16, 0.16, 0.16, 0.16, 0.16, 0.17, 0.18, 0.19, 0.2, 0.21, 0.22, 0.23, 0.24, 0.25, 0.25, 0.26, 0.26, 0.27, 0.27, 0.27, 0.27, 0.27, 0.27, 0.27, 0.27, 0.27, 0.27, 0.26, 0.25, 0.25, 0.24, 0.24, 0.23, 0.22, 0.22, 0.22, 0.22, 0.22, 0.23, 0.24, 0.25, 0.26, 0.28, 0.31, 0.34, 0.37, 0.4, 0.42, 0.43, 0.41, 0.39, 0.38, 0.37, 0.37, 0.37, 0.38, 0.4, 0.41, 0.43, 0.42, 0.39, 0.37, 0.36, 0.35, 0.35, 0.34, 0.34, 0.34, 0.35, 0.36, 0.37, 0.39, 0.4, 0.41, 0.42, 0.42, 0.43, 0.43, 0.42, 0.42, 0.42, 0.41, 0.4, 0.4, 0.4, 0.41, 0.41, 0.42, 0.43, 0.43, 0.41, 0.41, 0.39, 0.38, 0.36, 0.35, 0.35, 0.35, 0.35, 0.35, 0.35, 0.35, 0.34, 0.34, 0.33, 0.33, 0.33, 0.33, 0.33, 0.33, 0.33, 0.33, 0.33, 0.34, 0.36, 0.38, 0.39, 0.38, 0.37, 0.36, 0.35, 0.35, 0.34, 0.33, 0.32, 0.3, 0.28, 0.27, 0.26, 0.26, 0.26, 0.26, 0.25, 0.26, 0.26, 0.27, 0.28, 0.3, 0.31, 0.32, 0.33, 0.34, 0.34, 0.34, 0.31, 0.29, 0.27, 0.24, 0.21, 0.19, 0.17, 0.15, 0.14, 0.13, 0.12, 0.12, 0.13, 0.14, 0.15, 0.18, 0.19, 0.21, 0.23, 0.25, 0.28, 0.3, 0.32, 0.33, 0.32, 0.28, 0.25, 0.22, 0.2, 0.17, 0.15, 0.12, 0.1, 0.08, 0.06, 0.06, 0.06, 0.05, 0.05, 0.05, 0.04, 0.04, 0.04, 0.04, 0.03, 0.03, 0.03, 0.02, 0.02, 0.02, 0.02, 0.03, 0.03, 0.03, 0.04, 0.05, 0.06, 0.07, 0.09, 0.09, 0.1, 0.09, 0.08, 0.07, 0.07, 0.05, 0.04, 0.04, 0.03, 0.03, 0.03, 0.02, 0.03, 0.03, 0.03, 0.03, 0.03, 0.03, 0.04, 0.04, 0.04, 0.04, 0.05, 0.05, 0.05, 0.05, 0.05, 0.05, 0.06, 0.06, 0.06, 0.07, 0.07, 0.07, 0.08, 0.08, 0.09, 0.1, 0.11, 0.11, 0.12, 0.12, 0.13, 0.14, 0.14, 0.15, 0.16, 0.18, 0.19, 0.21, 0.23, 0.26, 0.28, 0.3, 0.32, 0.33, 0.35, 0.36, 0.36, 0.37, 0.37, 0.37, 0.37, 0.37, 0.37, 0.38, 0.38, 0.38, 0.38, 0.38, 0.38, 0.39, 0.38, 0.38, 0.38, 0.38, 0.38, 0.37, 0.37, 0.37, 0.38, 0.38, 0.38, 0.39, 0.39, 0.39, 0.39, 0.4, 0.4, 0.41, 0.41, 0.42, 0.43, 0.42, 0.41, 0.4, 0.39, 0.38, 0.37, 0.36, 0.36, 0.36, 0.37, 0.38, 0.39, 0.4, 0.42, 0.43, 0.43, 0.42, 0.42, 0.41, 0.42, 0.42, 0.43, 0.43, 0.41, 0.38, 0.37, 0.35, 0.34, 0.33, 0.32, 0.32, 0.32, 0.33, 0.34, 0.38, 0.42, 0.4, 0.35, 0.3, 0.26, 0.22, 0.19, 0.16, 0.15, 0.13, 0.13, 0.12, 0.12, 0.13, 0.13, 0.13, 0.13, 0.13, 0.13, 0.13, 0.13, 0.13, 0.13, 0.13, 0.12, 0.12, 0.12, 0.12, 0.12, 0.12, 0.12, 0.11, 0.11, 0.1, 0.09, 0.09, 0.09, 0.08, 0.08, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.06, 0.05, 0.05, 0.05, 0.04, 0.04, 0.04, 0.04, 0.04, 0.04, 0.04, 0.05, 0.05, 0.06, 0.06, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.07, 0.08, 0.08, 0.08, 0.09, 0.1, 0.11, 0.12, 0.14, 0.15, 0.17, 0.18, 0.19, 0.21, 0.22, 0.23, 0.24, 0.24, 0.24, 0.25, 0.25, 0.26, 0.27, 0.28, 0.28, 0.3, 0.3, 0.32, 0.33, 0.34, 0.34, 0.35, 0.35, 0.35, 0.36, 0.37, 0.37, 0.37, 0.37, 0.37, 0.38, 0.39, 0.4, 0.41, 0.42, 0.42, 0.43, 0.43, 0.42, 0.41, 0.4, 0.39, 0.39, 0.39, 0.38, 0.37, 0.36, 0.36, 0.36, 0.36, 0.36, 0.35, 0.34, 0.33, 0.33, 0.34, 0.36, 0.38, 0.39, 0.4, 0.41, 0.43, 0.41, 0.39, 0.36, 0.34, 0.33, 0.33, 0.33, 0.32, 0.32, 0.31, 0.31, 0.3, 0.3, 0.3, 0.3, 0.3, 0.29, 0.29, 0.29, 0.27, 0.27, 0.26, 0.26, 0.26, 0.25, 0.24, 0.24, 0.24, 0.23, 0.23, 0.24, 0.24, 0.25, 0.25, 0.26, 0.26, 0.27, 0.28, 0.29, 0.29, 0.28, 0.27, 0.26, 0.25, 0.23, 0.22, 0.22, 0.21, 0.19, 0.18, 0.18, 0.17, 0.17, 0.17, 0.17, 0.17, 0.17, 0.17, 0.17, 0.17, 0.18, 0.19, 0.2, 0.21, 0.21, 0.22, 0.23, 0.25, 0.26, 0.26, 0.27, 0.27, 0.27, 0.27, 0.27, 0.28, 0.28, 0.27, 0.26, 0.25, 0.25, 0.25, 0.25, 0.25, 0.24, 0.23, 0.22, 0.21, 0.21, 0.2, 0.2, 0.18, 0.17, 0.16, 0.15, 0.14, 0.14, 0.15, 0.15, 0.15, 0.16, 0.17, 0.18, 0.19, 0.21, 0.22, 0.23, 0.22, 0.22, 0.21, 0.2, 0.19, 0.18, 0.17, 0.17, 0.16, 0.17, 0.18, 0.19, 0.21, 0.23, 0.25, 0.27, 0.28, 0.3, 0.31, 0.31, 0.29, 0.27, 0.24, 0.22, 0.21, 0.19, 0.17, 0.16, 0.14, 0.12, 0.1, 0.1, 0.1, 0.09, 0.08, 0.07, 0.07, 0.06, 0.05, 0.06, 0.06, 0.06, 0.06, 0.05, 0.06, 0.06, 0.07, 0.08, 0.09, 0.11, 0.11, 0.13, 0.14, 0.16, 0.19, 0.21, 0.23, 0.24, 0.23, 0.22, 0.22, 0.21, 0.2, 0.19, 0.18, 0.16, 0.13, 0.1, 0.09, 0.09, 0.08, 0.08, 0.07, 0.07, 0.06, 0.06, 0.06, 0.08, 0.1, 0.12, 0.13, 0.15, 0.18, 0.21, 0.24, 0.27, 0.3, 0.31, 0.3, 0.28, 0.26, 0.24, 0.22, 0.19, 0.17, 0.14, 0.13, 0.13, 0.12, 0.11, 0.12, 0.12, 0.13, 0.13, 0.14, 0.15, 0.17, 0.18, 0.18, 0.19, 0.21, 0.22, 0.22, 0.23, 0.24, 0.25, 0.25, 0.24, 0.24, 0.24, 0.24, 0.23, 0.22, 0.22, 0.21, 0.2, 0.2, 0.2, 0.2, 0.2, 0.2, 0.2, 0.2, 0.21, 0.22, 0.23, 0.23, 0.22, 0.22, 0.21, 0.2, 0.2, 0.2, 0.19, 0.19, 0.18, 0.18, 0.17, 0.17, 0.17, 0.16, 0.16, 0.16, 0.16, 0.17, 0.17, 0.17, 0.17, 0.17, 0.18, 0.2, 0.21, 0.23, 0.24, 0.26, 0.26, 0.28, 0.3, 0.32, 0.33, 0.34, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.36, 0.37, 0.37, 0.38, 0.4, 0.41, 0.42, 0.43, 0.43, 0.42, 0.41, 0.4, 0.39, 0.39, 0.38, 0.38, 0.38, 0.38, 0.38, 0.38, 0.39, 0.4, 0.4, 0.4, 0.41, 0.42, 0.43, 0.42, 0.42, 0.41, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.41, 0.42, 0.42, 0.43, 0.43, 0.42, 0.41, 0.4, 0.4, 0.4, 0.39, 0.4, 0.39, 0.39, 0.39, 0.39, 0.39, 0.4, 0.4, 0.39, 0.39, 0.39, 0.38, 0.38, 0.4, 0.41, 0.42, 0.43, 0.43, 0.42, 0.41, 0.39, 0.38, 0.37, 0.37, 0.38, 0.39, 0.4, 0.43, 0.42, 0.43, 0.43, 0.43, 0.43, 0.42, 0.42, 0.41, 0.4, 0.39, 0.38, 0.38, 0.37, 0.37, 0.37, 0.38, 0.38, 0.38, 0.39, 0.4, 0.39, 0.39, 0.39, 0.39, 0.38, 0.37, 0.37, 0.37, 0.37, 0.36, 0.36, 0.37, 0.37, 0.38, 0.39, 0.4, 0.4, 0.4, 0.4, 0.39, 0.38, 0.38, 0.35, 0.33, 0.31, 0.29, 0.29, 0.28, 0.26, 0.25, 0.23, 0.22, 0.2, 0.19, 0.19, 0.19, 0.19, 0.18, 0.18, 0.19, 0.2, 0.21, 0.23, 0.25, 0.26, 0.26, 0.26, 0.26, 0.26, 0.25, 0.24, 0.24, 0.24, 0.23, 0.24, 0.25, 0.27, 0.29, 0.31, 0.32, 0.35, 0.37, 0.38, 0.39, 0.4, 0.42, 0.42, 0.41, 0.41, 0.41, 0.41, 0.4, 0.4, 0.39, 0.39, 0.39, 0.38, 0.37, 0.37, 0.37, 0.36, 0.36, 0.36, 0.36, 0.36, 0.35, 0.35, 0.34, 0.34, 0.34, 0.34, 0.34, 0.33, 0.33, 0.32, 0.32, 0.32, 0.32, 0.32, 0.32, 0.34, 0.35, 0.35, 0.36, 0.37, 0.38, 0.38, 0.38, 0.38, 0.38, 0.38, 0.37, 0.36, 0.35, 0.34, 0.33, 0.33, 0.34, 0.34, 0.35, 0.35, 0.36, 0.38, 0.39, 0.4, 0.41, 0.41, 0.42, 0.42, 0.43, 0.43, 0.41, 0.41, 0.42, 0.42, 0.4, 0.39, 0.38, 0.38, 0.38, 0.38, 0.39, 0.4, 0.4, 0.4, 0.4, 0.41, 0.42, 0.42, 0.42, 0.43, 0.43, 0.43, 0.43, 0.43, 0.42, 0.42, 0.42, 0.41, 0.41, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.4, 0.41, 0.41, 0.42, 0.42, 0.43, 0.43, 0.43, 0.43, 0.43, 0.43, 0.43, 0.43, 0.42, 0.42, 0.43, 0.43, 0.42, 0.43, 0.42, 0.42, 0.42, 0.41, 0.41, 0.41, 0.41, 0.4, 0.4, 0.4, 0.39]}]}, {"name": "Disordered regions", "provenance_source": "IUPred2(short)", "type": "disorder", "feature_positions": [{"beg_seq_id": 1, "values": [0.68, 0.65, 0.61, 0.56, 0.53, 0.42, 0.29, 0.25, 0.21, 0.17, 0.1, 0.12, 0.13, 0.13, 0.16, 0.13, 0.08, 0.09, 0.15, 0.15, 0.15, 0.21, 0.2, 0.2, 0.15, 0.16, 0.15, 0.23, 0.22, 0.21, 0.21, 0.2, 0.2, 0.1, 0.09, 0.09, 0.1, 0.14, 0.09, 0.07, 0.1, 0.07, 0.06, 0.04, 0.04, 0.04, 0.04, 0.06, 0.04, 0.03, 0.04, 0.03, 0.04, 0.04, 0.09, 0.06, 0.06, 0.06, 0.06, 0.15, 0.13, 0.15, 0.24, 0.13, 0.12, 0.09, 0.15, 0.1, 0.05, 0.09, 0.06, 0.03, 0.05, 0.04, 0.04, 0.02, 0.04, 0.03, 0.03, 0.03, 0.03, 0.02, 0.02, 0.03, 0.06, 0.09, 0.13, 0.12, 0.13, 0.2, 0.22, 0.23, 0.31, 0.32, 0.37, 0.32, 0.35, 0.35, 0.24, 0.3, 0.29, 0.3, 0.37, 0.26, 0.26, 0.19, 0.12, 0.12, 0.13, 0.18, 0.17, 0.11, 0.13, 0.14, 0.09, 0.05, 0.08, 0.07, 0.04, 0.1, 0.09, 0.08, 0.09, 0.1, 0.2, 0.19, 0.2, 0.31, 0.32, 0.21, 0.21, 0.23, 0.25, 0.22, 0.2, 0.25, 0.31, 0.25, 0.14, 0.2, 0.07, 0.07, 0.07, 0.04, 0.04, 0.04, 0.03, 0.04, 0.04, 0.03, 0.01, 0.01, 0.01, 0.01, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.01, 0.01, 0.01, 0.01, 0.01, 0.04, 0.15, 0.17, 0.16, 0.18, 0.16, 0.17, 0.18, 0.26, 0.39, 0.48, 0.47, 0.43, 0.46, 0.48, 0.55, 0.51, 0.46, 0.54, 0.45, 0.45, 0.54, 0.53, 0.53, 0.55, 0.49, 0.46, 0.38, 0.41, 0.41, 0.44, 0.44, 0.48, 0.43, 0.38, 0.33, 0.33, 0.38, 0.44, 0.41, 0.49, 0.46, 0.43, 0.41, 0.32, 0.23, 0.29, 0.35, 0.42, 0.39, 0.31, 0.27, 0.25, 0.2, 0.27, 0.32, 0.27, 0.26, 0.2, 0.19, 0.19, 0.13, 0.1, 0.1, 0.06, 0.09, 0.08, 0.08, 0.04, 0.04, 0.05, 0.05, 0.07, 0.08, 0.08, 0.06, 0.05, 0.09, 0.09, 0.13, 0.08, 0.08, 0.13, 0.2, 0.13, 0.21, 0.13, 0.2, 0.21, 0.23, 0.14, 0.14, 0.18, 0.12, 0.12, 0.12, 0.15, 0.16, 0.17, 0.17, 0.11, 0.17, 0.18, 0.1, 0.09, 0.09, 0.06, 0.11, 0.12, 0.09, 0.08, 0.14, 0.13, 0.07, 0.1, 0.09, 0.15, 0.13, 0.11, 0.06, 0.06, 0.06, 0.05, 0.05, 0.05, 0.05, 0.09, 0.07, 0.04, 0.03, 0.04, 0.05, 0.03, 0.03, 0.06, 0.03, 0.08, 0.08, 0.11, 0.11, 0.17, 0.17, 0.22, 0.17, 0.18, 0.21, 0.14, 0.08, 0.15, 0.24, 0.2, 0.2, 0.26, 0.25, 0.22, 0.23, 0.32, 0.3, 0.21, 0.2, 0.2, 0.17, 0.15, 0.18, 0.18, 0.16, 0.19, 0.27, 0.26, 0.17, 0.17, 0.24, 0.24, 0.28, 0.36, 0.38, 0.38, 0.31, 0.29, 0.4, 0.32, 0.24, 0.24, 0.21, 0.2, 0.29, 0.2, 0.21, 0.15, 0.23, 0.24, 0.18, 0.18, 0.18, 0.16, 0.16, 0.15, 0.15, 0.22, 0.15, 0.15, 0.14, 0.2, 0.23, 0.3, 0.22, 0.15, 0.23, 0.23, 0.22, 0.25, 0.32, 0.35, 0.36, 0.28, 0.27, 0.3, 0.3, 0.3, 0.23, 0.25, 0.16, 0.24, 0.17, 0.17, 0.1, 0.18, 0.18, 0.18, 0.18, 0.26, 0.16, 0.16, 0.12, 0.07, 0.12, 0.1, 0.05, 0.04, 0.05, 0.05, 0.08, 0.12, 0.12, 0.18, 0.17, 0.22, 0.12, 0.15, 0.1, 0.06, 0.06, 0.1, 0.1, 0.13, 0.18, 0.13, 0.09, 0.09, 0.1, 0.1, 0.11, 0.12, 0.12, 0.07, 0.04, 0.05, 0.06, 0.06, 0.04, 0.04, 0.06, 0.03, 0.03, 0.03, 0.03, 0.03, 0.05, 0.07, 0.12, 0.07, 0.03, 0.02, 0.02, 0.02, 0.03, 0.03, 0.02, 0.02, 0.02, 0.02, 0.04, 0.04, 0.06, 0.04, 0.04, 0.07, 0.07, 0.05, 0.04, 0.04, 0.04, 0.08, 0.05, 0.05, 0.03, 0.02, 0.02, 0.02, 0.03, 0.03, 0.05, 0.02, 0.01, 0.01, 0.02, 0.01, 0.02, 0.02, 0.02, 0.04, 0.02, 0.03, 0.02, 0.04, 0.04, 0.06, 0.05, 0.05, 0.03, 0.03, 0.02, 0.01, 0.01, 0.03, 0.01, 0.01, 0.01, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.0, 0.01, 0.01, 0.01, 0.01, 0.02, 0.04, 0.04, 0.03, 0.07, 0.12, 0.13, 0.13, 0.19, 0.17, 0.12, 0.19, 0.28, 0.23, 0.24, 0.3, 0.3, 0.27, 0.35, 0.28, 0.38, 0.35, 0.28, 0.38, 0.35, 0.36, 0.36, 0.38, 0.38, 0.41, 0.43, 0.51, 0.5, 0.52, 0.59, 0.58, 0.6, 0.55, 0.54, 0.53, 0.63, 0.58, 0.55, 0.61, 0.53, 0.61, 0.58, 0.52, 0.57, 0.56, 0.51, 0.5, 0.49, 0.5, 0.45, 0.38, 0.3, 0.2, 0.27, 0.28, 0.24, 0.24, 0.21, 0.18, 0.18, 0.26, 0.27, 0.19, 0.16, 0.11, 0.11, 0.07, 0.05, 0.05, 0.04, 0.05, 0.07, 0.08, 0.12, 0.09, 0.08, 0.06, 0.03, 0.06, 0.05, 0.05, 0.03, 0.02, 0.05, 0.06, 0.06, 0.06, 0.09, 0.15, 0.15, 0.1, 0.06, 0.07, 0.05, 0.05, 0.06, 0.05, 0.09, 0.13, 0.07, 0.12, 0.12, 0.13, 0.12, 0.11, 0.07, 0.06, 0.03, 0.02, 0.01, 0.02, 0.02, 0.04, 0.04, 0.03, 0.02, 0.01, 0.02, 0.02, 0.02, 0.02, 0.01, 0.0, 0.0, 0.0, 0.0, 0.0, 0.01, 0.01, 0.01, 0.01, 0.0, 0.0, 0.0, 0.0, 0.01, 0.01, 0.01, 0.01, 0.01, 0.01, 0.01, 0.01, 0.02, 0.04, 0.02, 0.02, 0.02, 0.03, 0.04, 0.05, 0.08, 0.09, 0.12, 0.13, 0.09, 0.05, 0.06, 0.06, 0.05, 0.05, 0.06, 0.07, 0.05, 0.06, 0.07, 0.11, 0.12, 0.18, 0.17, 0.22, 0.25, 0.26, 0.33, 0.31, 0.2, 0.29, 0.29, 0.36, 0.37, 0.38, 0.39, 0.4, 0.38, 0.39, 0.38, 0.31, 0.25, 0.26, 0.27, 0.29, 0.24, 0.22, 0.21, 0.23, 0.19, 0.27, 0.22, 0.3, 0.29, 0.29, 0.38, 0.37, 0.28, 0.23, 0.27, 0.3, 0.35, 0.41, 0.4, 0.35, 0.35, 0.35, 0.27, 0.3, 0.27, 0.34, 0.35, 0.4, 0.4, 0.41, 0.37, 0.37, 0.3, 0.3, 0.31, 0.35, 0.32, 0.32, 0.22, 0.24, 0.27, 0.27, 0.26, 0.33, 0.31, 0.24, 0.18, 0.14, 0.13, 0.12, 0.07, 0.09, 0.05, 0.08, 0.1, 0.15, 0.14, 0.1, 0.07, 0.09, 0.08, 0.05, 0.09, 0.14, 0.09, 0.08, 0.12, 0.13, 0.09, 0.09, 0.09, 0.14, 0.1, 0.1, 0.09, 0.11, 0.11, 0.07, 0.07, 0.07, 0.09, 0.05, 0.08, 0.06, 0.03, 0.04, 0.03, 0.04, 0.05, 0.09, 0.09, 0.1, 0.07, 0.07, 0.13, 0.07, 0.05, 0.03, 0.05, 0.09, 0.11, 0.13, 0.19, 0.16, 0.13, 0.14, 0.17, 0.19, 0.18, 0.18, 0.18, 0.21, 0.14, 0.12, 0.17, 0.16, 0.15, 0.21, 0.26, 0.24, 0.16, 0.13, 0.13, 0.13, 0.16, 0.23, 0.23, 0.16, 0.13, 0.08, 0.09, 0.06, 0.06, 0.1, 0.08, 0.09, 0.09, 0.11, 0.11, 0.1, 0.11, 0.11, 0.13, 0.15, 0.14, 0.09, 0.05, 0.06, 0.06, 0.07, 0.1, 0.09, 0.07, 0.04, 0.04, 0.06, 0.06, 0.06, 0.06, 0.04, 0.05, 0.03, 0.05, 0.05, 0.03, 0.03, 0.03, 0.05, 0.06, 0.06, 0.05, 0.03, 0.03, 0.05, 0.08, 0.05, 0.07, 0.07, 0.07, 0.08, 0.11, 0.06, 0.12, 0.1, 0.06, 0.1, 0.06, 0.12, 0.12, 0.1, 0.13, 0.11, 0.15, 0.14, 0.15, 0.15, 0.13, 0.07, 0.07, 0.08, 0.05, 0.05, 0.07, 0.07, 0.04, 0.07, 0.05, 0.08, 0.08, 0.09, 0.11, 0.08, 0.13, 0.12, 0.08, 0.08, 0.07, 0.08, 0.12, 0.13, 0.08, 0.12, 0.14, 0.17, 0.19, 0.19, 0.19, 0.27, 0.26, 0.16, 0.16, 0.13, 0.19, 0.18, 0.18, 0.18, 0.19, 0.15, 0.14, 0.15, 0.15, 0.14, 0.11, 0.1, 0.08, 0.07, 0.12, 0.07, 0.07, 0.04, 0.07, 0.07, 0.06, 0.05, 0.03, 0.05, 0.08, 0.04, 0.07, 0.09, 0.09, 0.09, 0.08, 0.06, 0.08, 0.1, 0.1, 0.1, 0.1, 0.08, 0.1, 0.06, 0.07, 0.06, 0.08, 0.06, 0.07, 0.04, 0.08, 0.05, 0.06, 0.06, 0.06, 0.08, 0.1, 0.09, 0.1, 0.07, 0.06, 0.08, 0.06, 0.05, 0.09, 0.04, 0.04, 0.02, 0.05, 0.04, 0.07, 0.05, 0.05, 0.03, 0.03, 0.04, 0.05, 0.06, 0.04, 0.04, 0.04, 0.05, 0.06, 0.1, 0.1, 0.1, 0.17, 0.26, 0.31, 0.23, 0.24, 0.19, 0.2, 0.29, 0.37, 0.38, 0.31, 0.31, 0.29, 0.4, 0.37, 0.41, 0.42, 0.36, 0.37, 0.38, 0.38, 0.38, 0.37, 0.41, 0.48, 0.48, 0.53, 0.52, 0.54, 0.53, 0.49, 0.55, 0.47, 0.5, 0.47, 0.5, 0.5, 0.43, 0.44, 0.39, 0.47, 0.38, 0.38, 0.38, 0.31, 0.29, 0.23, 0.23, 0.29, 0.24, 0.18, 0.23, 0.21, 0.23, 0.16, 0.15, 0.15, 0.1, 0.13, 0.21, 0.17, 0.11, 0.15, 0.15, 0.14, 0.23, 0.25, 0.29, 0.29, 0.21, 0.23, 0.29, 0.21, 0.19, 0.26, 0.33, 0.31, 0.24, 0.33, 0.32, 0.29, 0.31, 0.38, 0.32, 0.33, 0.3, 0.21, 0.22, 0.15, 0.11, 0.15, 0.15, 0.09, 0.15, 0.16, 0.17, 0.13, 0.15, 0.14, 0.16, 0.13, 0.13, 0.2, 0.19, 0.26, 0.29, 0.23, 0.3, 0.22, 0.23, 0.25, 0.18, 0.18, 0.24, 0.2, 0.12, 0.11, 0.16, 0.12, 0.19, 0.13, 0.15, 0.09, 0.05, 0.05, 0.04, 0.04, 0.06, 0.05, 0.08, 0.07, 0.1, 0.14, 0.16, 0.12, 0.1, 0.15, 0.16, 0.1, 0.13, 0.07, 0.1, 0.06, 0.1, 0.18, 0.16, 0.11, 0.11, 0.07, 0.08, 0.09, 0.09, 0.1, 0.11, 0.08, 0.08, 0.07, 0.09, 0.09, 0.1, 0.1, 0.12, 0.07, 0.12, 0.07, 0.07, 0.1, 0.09, 0.08, 0.08, 0.09, 0.1, 0.17, 0.15, 0.1, 0.07, 0.12, 0.17, 0.17, 0.17, 0.23, 0.25, 0.35, 0.35, 0.35, 0.35, 0.35, 0.31, 0.32, 0.27, 0.37, 0.33, 0.32, 0.31, 0.33, 0.35, 0.43, 0.36, 0.33, 0.26, 0.2, 0.2, 0.21, 0.19, 0.28, 0.27, 0.35, 0.32, 0.35, 0.33, 0.31, 0.28, 0.31, 0.28, 0.28, 0.19, 0.25, 0.27, 0.34, 0.36, 0.37, 0.35, 0.24, 0.22, 0.15, 0.14, 0.11, 0.07, 0.04, 0.03, 0.04, 0.06, 0.07, 0.05, 0.04, 0.04, 0.05, 0.04, 0.04, 0.04, 0.04, 0.07, 0.11, 0.11, 0.11, 0.16, 0.18, 0.17, 0.23, 0.25, 0.28, 0.36, 0.39, 0.32, 0.36, 0.45, 0.46, 0.49, 0.47, 0.47, 0.43, 0.4, 0.35, 0.35, 0.44, 0.45, 0.38, 0.36, 0.43, 0.41, 0.42, 0.43, 0.43, 0.41, 0.48, 0.49, 0.47, 0.47, 0.38, 0.39, 0.41, 0.36, 0.37, 0.36, 0.37, 0.31, 0.35, 0.46, 0.5, 0.54, 0.61, 0.69, 0.72, 0.76, 0.79, 0.82]}]}], "rcsb_polymer_entity_feature_summary": [{"count": 7, "coverage": 0.79148, "type": "Pfam"}], "rcsb_polymer_entity_group_membership": [{"aggregation_method": "sequence_identity", "group_id": "14390_95", "similarity_cutoff": 95.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 1338, "ref_beg_seq_id": 1}]}, {"aggregation_method": "sequence_identity", "group_id": "1401_50", "similarity_cutoff": 50.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 60, "ref_beg_seq_id": 33}, {"entity_beg_seq_id": 61, "length": 5, "ref_beg_seq_id": 96}, {"entity_beg_seq_id": 66, "length": 70, "ref_beg_seq_id": 102}, {"entity_beg_seq_id": 136, "length": 38, "ref_beg_seq_id": 173}, {"entity_beg_seq_id": 174, "length": 1, "ref_beg_seq_id": 233}, {"entity_beg_seq_id": 175, "length": 6, "ref_beg_seq_id": 235}, {"entity_beg_seq_id": 181, "length": 8, "ref_beg_seq_id": 260}, {"entity_beg_seq_id": 189, "length": 5, "ref_beg_seq_id": 279}, {"entity_beg_seq_id": 194, "length": 17, "ref_beg_seq_id": 308}, {"entity_beg_seq_id": 211, "length": 17, "ref_beg_seq_id": 329}, {"entity_beg_seq_id": 228, "length": 34, "ref_beg_seq_id": 375}, {"entity_beg_seq_id": 262, "length": 39, "ref_beg_seq_id": 417}, {"entity_beg_seq_id": 301, "length": 25, "ref_beg_seq_id": 457}, {"entity_beg_seq_id": 326, "length": 59, "ref_beg_seq_id": 487}, {"entity_beg_seq_id": 385, "length": 3, "ref_beg_seq_id": 549}, {"entity_beg_seq_id": 388, "length": 65, "ref_beg_seq_id": 553}, {"entity_beg_seq_id": 453, "length": 84, "ref_beg_seq_id": 628}, {"entity_beg_seq_id": 537, "length": 115, "ref_beg_seq_id": 725}, {"entity_beg_seq_id": 652, "length": 68, "ref_beg_seq_id": 841}, {"entity_beg_seq_id": 720, "length": 15, "ref_beg_seq_id": 910}, {"entity_beg_seq_id": 735, "length": 217, "ref_beg_seq_id": 931}, {"entity_beg_seq_id": 952, "length": 9, "ref_beg_seq_id": 1152}, {"entity_beg_seq_id": 961, "length": 193, "ref_beg_seq_id": 1162}, {"entity_beg_seq_id": 1154, "length": 2, "ref_beg_seq_id": 1358}, {"entity_beg_seq_id": 1156, "length": 68, "ref_beg_seq_id": 1361}, {"entity_beg_seq_id": 1224, "length": 34, "ref_beg_seq_id": 1436}, {"entity_beg_seq_id": 1258, "length": 39, "ref_beg_seq_id": 1472}, {"entity_beg_seq_id": 1297, "length": 29, "ref_beg_seq_id": 1515}, {"entity_beg_seq_id": 1326, "length": 13, "ref_beg_seq_id": 1549}]}, {"aggregation_method": "sequence_identity", "group_id": "1192_30", "similarity_cutoff": 30.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 18, "ref_beg_seq_id": 35}, {"entity_beg_seq_id": 19, "length": 24, "ref_beg_seq_id": 55}, {"entity_beg_seq_id": 43, "length": 5, "ref_beg_seq_id": 80}, {"entity_beg_seq_id": 48, "length": 13, "ref_beg_seq_id": 101}, {"entity_beg_seq_id": 61, "length": 2, "ref_beg_seq_id": 117}, {"entity_beg_seq_id": 63, "length": 3, "ref_beg_seq_id": 157}, {"entity_beg_seq_id": 66, "length": 30, "ref_beg_seq_id": 161}, {"entity_beg_seq_id": 96, "length": 37, "ref_beg_seq_id": 196}, {"entity_beg_seq_id": 133, "length": 3, "ref_beg_seq_id": 247}, {"entity_beg_seq_id": 136, "length": 2, "ref_beg_seq_id": 256}, {"entity_beg_seq_id": 138, "length": 10, "ref_beg_seq_id": 260}, {"entity_beg_seq_id": 148, "length": 22, "ref_beg_seq_id": 275}, {"entity_beg_seq_id": 170, "length": 5, "ref_beg_seq_id": 344}, {"entity_beg_seq_id": 175, "length": 1, "ref_beg_seq_id": 350}, {"entity_beg_seq_id": 176, "length": 13, "ref_beg_seq_id": 352}, {"entity_beg_seq_id": 189, "length": 2, "ref_beg_seq_id": 393}, {"entity_beg_seq_id": 191, "length": 3, "ref_beg_seq_id": 412}, {"entity_beg_seq_id": 194, "length": 11, "ref_beg_seq_id": 423}, {"entity_beg_seq_id": 205, "length": 9, "ref_beg_seq_id": 439}, {"entity_beg_seq_id": 214, "length": 20, "ref_beg_seq_id": 450}, {"entity_beg_seq_id": 234, "length": 25, "ref_beg_seq_id": 502}, {"entity_beg_seq_id": 259, "length": 3, "ref_beg_seq_id": 531}, {"entity_beg_seq_id": 262, "length": 12, "ref_beg_seq_id": 542}, {"entity_beg_seq_id": 274, "length": 27, "ref_beg_seq_id": 556}, {"entity_beg_seq_id": 301, "length": 24, "ref_beg_seq_id": 588}, {"entity_beg_seq_id": 325, "length": 39, "ref_beg_seq_id": 628}, {"entity_beg_seq_id": 364, "length": 18, "ref_beg_seq_id": 671}, {"entity_beg_seq_id": 382, "length": 5, "ref_beg_seq_id": 691}, {"entity_beg_seq_id": 387, "length": 1, "ref_beg_seq_id": 704}, {"entity_beg_seq_id": 388, "length": 35, "ref_beg_seq_id": 709}, {"entity_beg_seq_id": 423, "length": 12, "ref_beg_seq_id": 764}, {"entity_beg_seq_id": 435, "length": 17, "ref_beg_seq_id": 777}, {"entity_beg_seq_id": 452, "length": 17, "ref_beg_seq_id": 804}, {"entity_beg_seq_id": 469, "length": 16, "ref_beg_seq_id": 822}, {"entity_beg_seq_id": 485, "length": 1, "ref_beg_seq_id": 839}, {"entity_beg_seq_id": 486, "length": 21, "ref_beg_seq_id": 844}, {"entity_beg_seq_id": 507, "length": 14, "ref_beg_seq_id": 866}, {"entity_beg_seq_id": 521, "length": 16, "ref_beg_seq_id": 881}, {"entity_beg_seq_id": 537, "length": 4, "ref_beg_seq_id": 910}, {"entity_beg_seq_id": 541, "length": 2, "ref_beg_seq_id": 928}, {"entity_beg_seq_id": 543, "length": 9, "ref_beg_seq_id": 932}, {"entity_beg_seq_id": 552, "length": 13, "ref_beg_seq_id": 942}, {"entity_beg_seq_id": 565, "length": 30, "ref_beg_seq_id": 958}, {"entity_beg_seq_id": 595, "length": 57, "ref_beg_seq_id": 1064}, {"entity_beg_seq_id": 652, "length": 3, "ref_beg_seq_id": 1124}, {"entity_beg_seq_id": 655, "length": 44, "ref_beg_seq_id": 1132}, {"entity_beg_seq_id": 699, "length": 11, "ref_beg_seq_id": 1178}, {"entity_beg_seq_id": 710, "length": 13, "ref_beg_seq_id": 1208}, {"entity_beg_seq_id": 723, "length": 3, "ref_beg_seq_id": 1224}, {"entity_beg_seq_id": 726, "length": 3, "ref_beg_seq_id": 1229}, {"entity_beg_seq_id": 729, "length": 6, "ref_beg_seq_id": 1237}, {"entity_beg_seq_id": 735, "length": 3, "ref_beg_seq_id": 1249}, {"entity_beg_seq_id": 738, "length": 88, "ref_beg_seq_id": 1253}, {"entity_beg_seq_id": 826, "length": 126, "ref_beg_seq_id": 1350}, {"entity_beg_seq_id": 952, "length": 9, "ref_beg_seq_id": 1480}, {"entity_beg_seq_id": 961, "length": 1, "ref_beg_seq_id": 1490}, {"entity_beg_seq_id": 962, "length": 5, "ref_beg_seq_id": 1511}, {"entity_beg_seq_id": 967, "length": 34, "ref_beg_seq_id": 1526}, {"entity_beg_seq_id": 1001, "length": 19, "ref_beg_seq_id": 1568}, {"entity_beg_seq_id": 1020, "length": 45, "ref_beg_seq_id": 1588}, {"entity_beg_seq_id": 1065, "length": 15, "ref_beg_seq_id": 1644}, {"entity_beg_seq_id": 1080, "length": 36, "ref_beg_seq_id": 1661}, {"entity_beg_seq_id": 1116, "length": 2, "ref_beg_seq_id": 1701}, {"entity_beg_seq_id": 1118, "length": 11, "ref_beg_seq_id": 1722}, {"entity_beg_seq_id": 1129, "length": 25, "ref_beg_seq_id": 1768}, {"entity_beg_seq_id": 1154, "length": 3, "ref_beg_seq_id": 1801}, {"entity_beg_seq_id": 1157, "length": 7, "ref_beg_seq_id": 1805}, {"entity_beg_seq_id": 1164, "length": 61, "ref_beg_seq_id": 1814}, {"entity_beg_seq_id": 1225, "length": 3, "ref_beg_seq_id": 1882}, {"entity_beg_seq_id": 1228, "length": 30, "ref_beg_seq_id": 1886}, {"entity_beg_seq_id": 1258, "length": 22, "ref_beg_seq_id": 1918}, {"entity_beg_seq_id": 1280, "length": 17, "ref_beg_seq_id": 1941}, {"entity_beg_seq_id": 1297, "length": 3, "ref_beg_seq_id": 1962}, {"entity_beg_seq_id": 1300, "length": 26, "ref_beg_seq_id": 1984}, {"entity_beg_seq_id": 1326, "length": 13, "ref_beg_seq_id": 2015}]}, {"aggregation_method": "sequence_identity", "group_id": "12201_70", "similarity_cutoff": 70.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 651, "ref_beg_seq_id": 1}, {"entity_beg_seq_id": 652, "length": 687, "ref_beg_seq_id": 653}]}, {"aggregation_method": "sequence_identity", "group_id": "21235_100", "similarity_cutoff": 100.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 1338, "ref_beg_seq_id": 1}]}, {"aggregation_method": "sequence_identity", "group_id": "15900_90", "similarity_cutoff": 90.0, "aligned_regions": [{"entity_beg_seq_id": 1, "length": 1338, "ref_beg_seq_id": 1}]}, {"aggregation_method": "matching_uniprot_accession", "group_id": "Q06278", "aligned_regions": [{"entity_beg_seq_id": 1, "length": 1338, "ref_beg_seq_id": 1}]}], "rcsb_polymer_entity_name_com": [{"name": "ALDEHYDE OXIDASE 1, AZAHETEROCYCLE HYDROXYLASE"}], "rcsb_related_target_references": [{"related_resource_name": "ChEMBL", "related_resource_version": "36", "related_target_id": "CHEMBL4106157", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 1337, "target_beg_seq_id": 1}]}, {"related_resource_name": "ChEMBL", "related_resource_version": "36", "related_target_id": "CHEMBL3257", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 1337, "target_beg_seq_id": 1}]}, {"related_resource_name": "ChEMBL", "related_resource_version": "36", "related_target_id": "CHEMBL1641357", "target_taxonomy_id": 9541, "aligned_target": [{"entity_beg_seq_id": 1, "length": 1337, "target_beg_seq_id": 1}]}, {"related_resource_name": "DrugBank", "related_resource_version": "5.1", "related_target_id": "Q06278", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 1337, "target_beg_seq_id": 1}]}, {"related_resource_name": "Pharos", "related_resource_version": "6.13.4", "related_target_id": "15989", "target_taxonomy_id": 9606, "aligned_target": [{"entity_beg_seq_id": 1, "length": 1337, "target_beg_seq_id": 1}]}], "rcsb_target_cofactors": [{"binding_assay_value": 3.0, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "NULHWQZPYWXJLF-UHFFFAOYSA-N", "cofactor_smiles": "CCOP(=O)(CCC=O)c1ccccc1", "cofactor_resource_id": "CHEMBL103375", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3257"}, {"binding_assay_value": 3.0, "binding_assay_value_type": "pIC50", "cofactor_in_ch_ikey": "CZWCKYRVOZZJNM-USOAJAOKSA-N", "cofactor_smiles": "C[C@]12CC[C@H](OS(=O)(=O)O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12", "cofactor_chem_comp_id": "ZWY", "cofactor_name": "PRASTERONE SULFURIC ACID", "cofactor_resource_id": "CHEMBL259898", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3257"}, {"binding_assay_value": 2.7, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "FUBLLKKWKHVTTK-UHFFFAOYSA-N", "cofactor_smiles": "CCOP(=O)(CCC=O)OCC", "cofactor_resource_id": "CHEMBL316980", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3257"}, {"binding_assay_value": 2.7, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "WKPXMGJOGYEGNW-UHFFFAOYSA-N", "cofactor_smiles": "CCOC(CCP(=O)(OCC)OCC)OCC", "cofactor_resource_id": "CHEMBL102691", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3257"}, {"binding_assay_value": 2.52, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "ZZWQVTBJLLXLPJ-UHFFFAOYSA-N", "cofactor_smiles": "CCOP(=O)(CC=O)OCC", "cofactor_resource_id": "CHEMBL103253", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3257"}, {"binding_assay_value": 2.52, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "UTQRIKXKWDNRPY-UHFFFAOYSA-N", "cofactor_smiles": "CCOC(CCP(=O)(OCC)c1ccccc1)OCC", "cofactor_resource_id": "CHEMBL318466", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3257"}, {"binding_assay_value": 2.4, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "RBPMFEDBWLYWCX-UHFFFAOYSA-N", "cofactor_smiles": "CCOC(CP(=O)(OCC)c1ccccc1)OCC", "cofactor_resource_id": "CHEMBL318547", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3257"}, {"binding_assay_value": 1.82, "binding_assay_value_type": "pKi", "cofactor_in_ch_ikey": "LUQYELQXRPNKRY-UHFFFAOYSA-N", "cofactor_smiles": "CCOC(CP(=O)(OCC)OCC)OCC", "cofactor_resource_id": "CHEMBL105079", "neighbor_flag": "N", "resource_name": "ChEMBL", "resource_version": "36", "target_resource_id": "CHEMBL3257"}, {"cofactor_in_ch_ikey": "BOPGDPNILDQYTO-NNYOXOHSSA-N", "cofactor_smiles": "NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)N2C=NC3=C(N)N=CN=C23)[C@@H](O)[C@H]1O", "cofactor_chem_comp_id": "NAI", "cofactor_name": "NADH", "cofactor_resource_id": "DB00157", "mechanism_of_action": "NADH is synthesized by the body and thus is not an essential nutrient. It does require the essential nutrient nicotinamide for its synthesis, and its role in energy production is certainly an essential one. In addition to its role in the mitochondrial electron transport chain, NADH is produced in the cytosol. The mitochondrial membrane is impermeable to NADH, and this permeability barrier effectively separates the cytoplasmic from the mitochondrial NADH pools. However, cytoplasmic NADH can be used for biologic energy production. This occurs when the malate-aspartate shuttle introduces reducing equivalents from NADH in the cytosol to the electron transport chain of the mitochondria. This shuttle mainly occurs in the liver and heart.", "neighbor_flag": "N", "pubmed_ids": [10687026, 19801639], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "MJVAVZPDRWSRRC-UHFFFAOYSA-N", "cofactor_smiles": "CC1=CC(=O)C2=CC=CC=C2C1=O", "cofactor_chem_comp_id": "VK3", "cofactor_name": "Menadione", "cofactor_resource_id": "DB00170", "mechanism_of_action": "Menadione (vitamin K3) is involved as a cofactor in the posttranslational gamma-carboxylation of glutamic acid residues of certain proteins in the body. These proteins include the vitamin K-dependent coagulation factors II (prothrombin), VII (proconvertin), IX (Christmas factor), X (Stuart factor), protein C, protein S, protein Zv and a growth-arrest-specific factor (Gas6). In contrast to the other vitamin K-dependent proteins in the blood coagulation cascade, protein C and protein S serve anticoagulant roles. The two vitamin K-dependent proteins found in bone are osteocalcin, also known as bone G1a (gamma-carboxyglutamate) protein or BGP, and the matrix G1a protein or MGP. Gamma-carboxylation is catalyzed by the vitamin K-dependent gamma-carboxylases. The reduced form of vitamin K, vitamin K hydroquinone, is the actual cofactor for the gamma-carboxylases. Proteins containing gamma-carboxyglutamate are called G1a proteins.", "neighbor_flag": "N", "pubmed_ids": [37713619, 20853847, 39574417, 22996261], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "WSEQXVZVJXJVFP-UHFFFAOYSA-N", "cofactor_smiles": "CN(C)CCCC1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1", "cofactor_name": "Citalopram", "cofactor_resource_id": "DB00215", "mechanism_of_action": "The mechanism of action of citalopram is unclear but is presumed to be related to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT), potentially through the inhibition of the serotonin transporter (solute carrier family 6 member 4, _SLC6A4_).[L47941,A37688] \r\n\r\nCitalopram binds with significantly less affinity to histamine, acetylcholine, and norepinephrine receptors than tricyclic antidepressant drugs. Particularly, citalopram has no or very low affinity for 5-HT<sub>1A</sub>, 5-HT<sub>2A</sub>, dopamine D<sub>1</sub> and D<sub>2</sub>, \u03b1<sub>1</sub>-, \u03b1<sub>2</sub>-, and \u03b2-adrenergic, histamine H<sub>1</sub>, gamma aminobutyric acid (GABA), muscarinic cholinergic, and benzodiazepine receptors.[L47941]", "neighbor_flag": "N", "pubmed_ids": [21546862, 9698084, 10863884], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "MVWVFYHBGMAFLY-UHFFFAOYSA-N", "cofactor_smiles": "ClC1=C(CCN2CCN(CC2)C2=NSC3=CC=CC=C23)C=C2CC(=O)NC2=C1", "cofactor_chem_comp_id": "XEF", "cofactor_name": "Ziprasidone", "cofactor_resource_id": "DB00246", "mechanism_of_action": "The effects of ziprasidone are differentiated from other antispychotics based on its preference and affinity for certain receptors. Ziprasidone binds to serotonin-2A (5-HT2A) and dopamine D2 receptors in a similar fashion to other atypical antipsychotics; however, one key difference is that ziprasidone has a higher 5-HT2A/D2 receptor affinity ratio when compared to other antipsychotics such as olanzapine, quetiapine, risperidone, and aripiprazole.[A363]  Ziprasidone offers enhanced modulation of mood, notable negative symptom relief, overall cognitive improvement and reduced motor dysfunction which is linked to it's potent interaction with 5-HT2C, 5-HT1D, and 5-HT1A receptors in brain tissue.[A363] Ziprasidone can bind moderately to norepinephrine and serotonin reuptake sites which may contribute to its antidepressant and anxiolytic activity.[A363] Patient's taking ziprasidone will likely experience a lower incidence of orthostatic hypotension, cognitive disturbance, sedation, weight gain, and disruption in prolactin levels since ziprasidone has a lower affinity for histamine H1, muscarinic M1, and alpha1-adrenoceptors.[A363]  ", "neighbor_flag": "N", "pubmed_ids": [17214606], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "IPEHBUMCGVEMRF-UHFFFAOYSA-N", "cofactor_smiles": "NC(=O)C1=NC=CN=C1", "cofactor_chem_comp_id": "PZA", "cofactor_name": "Pyrazinamide", "cofactor_resource_id": "DB00339", "mechanism_of_action": "Pyrazinamide diffuses into active _M. tuberculosis_ that express pyrazinamidase enzyme that converts pyrazinamide to the active form pyrazinoic acid. Pyrazinoic acid can leak out under acidic conditions to be converted to the protonated conjugate acid, which is readily diffused back into the bacilli and accumulate intracellularly. The net effect is that more pyrazinoic acid accumulates inside the bacillus at acid pH than at neutral pH. Pyrazinoic acid was thought to inhibit the enzyme fatty acid synthase (FAS) I, which is required by the bacterium to synthesise fatty acids. However, this theory was thought to have been discounted.[A512] However, further studies reproduced the results of FAS I inhibition as the putative mechanism first in whole cell assay of replicating M. tuberculosis bacilli which have shown that pyrazinoic acid and its ester inhibit the synthesis of fatty acids.[A513] This study was followed by in vitro assay of tuberculous FAS I enzyme that tested the activity with pyrazinamide, pyrazinoic acid and several classes of pyrazinamide analogs. Pyrazinamide and its analogs inhibited the activity of purified FAS I.[A514] \r\n\r\nIt has also been suggested that the accumulation of pyrazinoic acid disrupts membrane potential and interferes with energy production, necessary for survival of M. tuberculosis at an acidic site of infection. Pyrazinoic acid has also been shown to bind to the ribosomal protein S1 (RpsA) and inhibit trans-translation. This may explain the ability of the drug to kill dormant mycobacteria.[A515]", "neighbor_flag": "N", "pubmed_ids": [8216357], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "GGXKWVWZWMLJEH-UHFFFAOYSA-N", "cofactor_smiles": "CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C12)COC(C)=O", "cofactor_name": "Famciclovir", "cofactor_resource_id": "DB00426", "mechanism_of_action": "Famciclovir undergoes rapid biotransformation to the active antiviral compound penciclovir, which has inhibitory activity against herpes simplex virus types 1 (HSV-1) and 2 (HSV-2) and varicella zoster virus (VZV). In cells infected with HSV-1, HSV-2 or VZV, viral thymidine kinase phosphorylates penciclovir to a monophosphate form that, in turn, is converted to penciclovir triphosphate by cellular kinases. In vitro studies demonstrate that penciclovir triphosphate inhibits HSV-2 DNA polymerase competitively with deoxyguanosine triphosphate. Consequently, herpes viral DNA synthesis and, therefore, replication are selectively inhibited.", "neighbor_flag": "N", "pubmed_ids": [9224775, 12161167], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "OFCNXPDARWKPPY-UHFFFAOYSA-N", "cofactor_smiles": "OC1=NC=NC2=C1C=NN2", "cofactor_chem_comp_id": "A1BD4", "cofactor_name": "Allopurinol", "cofactor_resource_id": "DB00437", "mechanism_of_action": "Allopurinol is a structural analog of the natural purine base, hypoxanthine.  After ingestion, allopurinol is metabolized to its active metabolite, oxypurinol (_alloxanthine_) in the liver [T508], which acts as an inhibitor of xanthine oxidase enzyme [FDA label]. \r\n\r\nAllopurinol and its active metabolite inhibit xanthine oxidase, the enzyme that converts hypoxanthine to xanthine and xanthine to uric acid. Inhibition of this enzyme is responsible for the effects of allopurinol. This drug increases the reutilization of hypoxanthine and xanthine for nucleotide and nucleic acid synthesis by a process that involves the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRTase).  This process results in an increased nucleotide concentration, which causes feedback inhibition of de novo purine synthesis. The end result is decreased urine and serum uric acid concentrations [F3988], which decreases the incidence of gout symptoms. \r\n\r\nAccompanying the reduction of serum uric acid by allopurinol is an increase in the serum and urine concentrations of hypoxanthine and xanthine (due to inhibition of xanthine oxidase).  In the absence of allopurinol, regular urinary excretion of oxypurines almost entirely occurs in the form of uric acid. After the ingestion of allopurinol, the contents of excreted urine are hypoxanthine, xanthine, and uric acid. Because each substance has its own individual solubility, the concentration of uric acid in plasma is decreased without exposing the renal tissues to a high load of uric acid, thereby decreasing the risk of crystalluria. By lowering the uric acid concentration in the plasma below its limits of solubility, allopurinol encourages the dissolution of gout tophi. Although the levels of hypoxanthine and xanthine are found to be increased after allopurinol ingestion, the risk of deposition in renal tissues is less than that of uric acid, as they become more soluble and are rapidly excreted by the kidney [F3988]. ", "neighbor_flag": "N", "pubmed_ids": [8216357], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "GZUITABIAKMVPG-UHFFFAOYSA-N", "cofactor_smiles": "OC1=CC=C(C=C1)C1=C(C(=O)C2=CC=C(OCCN3CCCCC3)C=C2)C2=C(S1)C=C(O)C=C2", "cofactor_chem_comp_id": "RAL", "cofactor_name": "Raloxifene", "cofactor_resource_id": "DB00481", "mechanism_of_action": "Raloxifene is a selective estrogen receptor modulator that acts as both an estrogen agonist and antagonist via differential effects on the tissue-specific estrogen receptors. Based on the findings of competitive binding assays, raloxifene displays binding affinity that is similar to that of [estradiol][A721], the predominant circulating estrogen.[A178861] Estrogens play variable roles at different tissues in females, including the bone, breasts, uterus and liver, by binding to the steroid nuclear hormone receptors, Estrogen Receptor alpha (ER\u03b1) or Estrogen Receptor beta (ER\u03b2).[A178861] These receptors are normally bound to the Heat Shock Protein 90 (Hsp90) when unbound to the ligand. Ligand binding induces a conformational change in the receptor that promotes dissociation of the receptor from Hsp90, dimerization and translocation into the nucleus. This movement into the nucleus allows the receptor to bind to genomic locations based on sequence recognition of the DNA binding domain, also known as the Estrogen Response Elements (EREs).[A178861] \r\n\r\nIn bones, endogenous estrogens normally modulate multiple DNA response elements, including the gene-encoding transforming growth factor-\u03b23 (TGF-\u03b23), which is a cytokine embedded in the bone matrix.[T28] TGF-\u03b23 plays an important role in bone remodelling[A178756] by working with other cytokines to induce production of osteoblasts, such as IL-6[A720], and attenuate the activity of osetoclasts. Estrogens typically maintain the bone integrity by inhibiting the cytokines that recruit osteoclasts and oppose the bone-resorbing, Ca2+-mobilizing action of parathyroid hormone. In contrast, estrogens promote osteoblast proliferation, augment the production of TGF-\u03b23 and bone morphogenic proteins, and inhibit apoptosis.[T28] Mimicking the action of endogenous estrogen in bone tissues, raloxifene binds to the estrogen receptor to influence gene transcription through interactions with the estrogen response element (ERE) and a distinct DNA target, the raloxifene response element (RRE).[A722] It occupies the same ER ligand binding site as estrogen.[A724] Upon binding, raloxifene induces a conformational change of the receptor, allowing mediation of direct binding to transcriptional elements by accessory proteins. Increased expression of bone matrix proteins, such as alkaline phosphatase, osteonectin, osteocalcin and collagen may be seen.[A722] The agonistic or antagonistic action of raloxifene depends on the extent of recruitment of coactivators and corepressors to estrogen receptor (ER) target gene promotors.[label] In breast tissues, raloxifene acts as an estrogen receptor antagonist to attenuate the estrogen-dependent proliferative effects of epithelial cell expansion. In addition to the antiproliferative effects, raloxifene prevents the production of cytokines and recruitment of macrophages and lymphocytes into tumor mass.[A178921]", "neighbor_flag": "Y", "pubmed_ids": [14709625, 14681337, 19356090, 34415167, 39574417, 20853847], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "XYLJNLCSTIOKRM-UHFFFAOYSA-N", "cofactor_smiles": "BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12", "cofactor_chem_comp_id": "J59", "cofactor_name": "Brimonidine", "cofactor_resource_id": "DB00484", "mechanism_of_action": "In the eye, alpha-1 adrenoceptors play a role in vasoconstriction, mydriasis, eyelid retraction, and elevation of intraocular pressure (IOP) whereas alpha-2 adrenoceptors are responsible for IOP reduction via a complex Gi-coupled signaling cascade pathway. Activation of alpha-2 receptors leads to inhibition of adenylyl cyclase and reduction of cyclic AMP levels. As a result, there is a decrease in norpinephrine (NE) release at the synaptic junction, NE-induced stimulation of beta-2 adrenoceptors, and production of aqueous humor by the ciliary epithelium.[A178969] An elevated IOP is the most significant risk factor for developing glaucomatous optic neuropathy, which is associated with progressive visual field loss and functional disability if left untreated.[A179002] Regardless of the etiology of the disease, the aim of current therapies for glaucoma is to reduce IOP, as reduction of IOP significantly reduces the risk of progression of vision loss even when IOP is already within the normal range.[A36674] When administered ophthalmically, brimonidine is rapidly absorbed into the eye, acts as an agonist at ocular alpha-2 adrenoceptors and lowers IOP via a dual mechanism of action.[A178981] It is proposed that initial dosing of the drug causes a reduction in aqueous humour production and chronic dosing leads to an increase in uveoscleral outflow.[A179002] Brimonidine does not affect episcleral venous pressure.[A178969] By reducing IOP, brimonidine aims to reduce the likelihood of glaucomatous visual field loss in ocular hypertension, and slow the progression of visual field defect in established open-angle glaucoma.[A178951] When applied topically on skin, brimonidine reduces erythema through direct vasocontriction of small arteries and veins.[A178978] As brimonidine mediates a potent peripheral vasoconstrictive activity by selectively working on the alpha-2 adrenoceptors, the use of brimonidine is thought to be efficacious for the treatment of facial erythema of rosacea, which is thought to arise from vasomotor instability and abnormal vasodilation of the superficial cutaneous vasculature of the face.[A178984]", "neighbor_flag": "N", "pubmed_ids": [8905918], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "SLXKOJJOQWFEFD-UHFFFAOYSA-N", "cofactor_smiles": "NCCCCCC(O)=O", "cofactor_chem_comp_id": "ACA", "cofactor_name": "Aminocaproic acid", "cofactor_resource_id": "DB00513", "mechanism_of_action": "Aminocaproic acid binds reversibly to the kringle domain of plasminogen and blocks the binding of plasminogen to fibrin and its activation to plasmin. With NO activation of plasmin, there is a reduction in fibrinolysis. This consequently will reduce the amount of bleeding post surgery. Elevated plasma levels of lipoprotein(a) have been shown to increase the risk of vascular disease. Lipoprotein 9a)a has two components, apolipoprotein B-100, linked to apolipoprotein (a). Aminocaproic acid may change the conformation of apoliprotein (a), changing its binding properties and potentially preventing the formation of lipoprotein (a).", "neighbor_flag": "N", "pubmed_ids": [2502880], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "FBOZXECLQNJBKD-ZDUSSCGKSA-N", "cofactor_smiles": "CN(CC1=CN=C2N=C(N)N=C(N)C2=N1)C1=CC=C(C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O", "cofactor_chem_comp_id": "MTX", "cofactor_name": "Methotrexate", "cofactor_resource_id": "DB00563", "mechanism_of_action": "Methotrexate enters tissues and is converted to a methotrexate polyglutamate by folylpolyglutamate.[A180322]\r\n\r\nMethotrexate's mechanism of action is due to its inhibition of enzymes responsible for nucleotide synthesis including  dihydrofolate reductase, thymidylate synthase, aminoimidazole caboxamide ribonucleotide transformylase (AICART), and amido phosphoribosyltransferase.[A180322] Inhibtion of nucleotide synthesis prevents cell division.\r\n\r\nIn rheumatoid arthritis, methotrexate polyglutamates inhibit AICART more than methotrexate.[A180322] This inhibition leads to accumulation of AICART ribonucleotide, which inhibits adenosine deaminase, leading to an accumulation of adenosine triphosphate and adenosine in the extracellular space, stimulating adenosine receptors, leading to anti-inflammatory action.[A180322]", "neighbor_flag": "N", "pubmed_ids": [20444863, 19644884, 10385213], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "UBQNRHZMVUUOMG-UHFFFAOYSA-N", "cofactor_smiles": "NS(=O)(=O)CC1=NOC2=CC=CC=C12", "cofactor_chem_comp_id": "ZON", "cofactor_name": "Zonisamide", "cofactor_resource_id": "DB00909", "mechanism_of_action": "The mechanism of action by which zonisamide controls seizures has not been fully established. However, its antiepileptic properties may be due to its effects on sodium and calcium channels.[L42530,L42535] Zonisamide blocks sodium channels and reduces voltage-dependent, transient inward currents, stabilizing neuronal membranes and suppressing neuronal hypersynchronization.[L42530,L42535] It affects T-type calcium currents, but has no effect on L-type calcium currents.[A1382,A1383,A1385] \r\n\r\nZonisamide suppresses synaptically-driven electrical activity by altering the synthesis, release, and degradation of neurotransmitters, such as glutamate, gamma-aminobutyric acid (GABA), dopamine, serotonin (5-hydroxytryptamine [5-HT]), and acetylcholine.[A1383,A1380] Furthermore, it binds to the GABA/benzodiazepine receptor ionophore complex without producing changes in chloride flux.[L42530,L42535] _In vitro_ studies have suggested that zonisamide does not affect postsynaptic GABA or glutamate responses, nor the neuronal or glial uptake of [<sup>3</sup>H]-GABA.", "neighbor_flag": "N", "pubmed_ids": [8742231, 11456132], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "JURKNVYFZMSNLP-UHFFFAOYSA-N", "cofactor_smiles": "CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12", "cofactor_name": "Cyclobenzaprine", "cofactor_resource_id": "DB00924", "mechanism_of_action": "The exact mechanism of action of cyclobenzaprine has not been fully elucidated in humans, and much of the information available regarding its mechanism has been ascertained from early animal studies. There is some evidence that cyclobenzaprine exerts its effects at the supraspinal level, specifically within the locus coeruleus of the brainstem, with little-to-no action at neuromuscular junctions or directly on skeletal musculature[L8411,A184982]. Action on the brainstem is thought to result in diminished activity of efferent alpha and gamma motor neurons, likely mediated by inhibition of coeruleus-spinal or reticulospinal pathways, and ultimately depressed spinal cord interneuron activity.[A184982]\r\n\r\nMore recently it has been suggested that inhibition of descending serotonergic pathways in the spinal cord via action on 5-HT2 receptors may contribute to cyclobenzaprine\u2019s observed effects.[A5896,A184982,A4862]", "neighbor_flag": "N", "pubmed_ids": [14681337], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "HUNXMJYCHXQEGX-UHFFFAOYSA-N", "cofactor_smiles": "CCN(C(C)=O)C1=CC=CC(=C1)C1=CC=NC2=C(C=NN12)C#N", "cofactor_name": "Zaleplon", "cofactor_resource_id": "DB00962", "mechanism_of_action": "Zaleplon exerts its action through subunit modulation of the GABA<sub>B</sub>Z receptor chloride channel macromolecular complex. Zaleplon also binds selectively to the brain omega-1 receptor located on the alpha subunit of the GABA-A/chloride ion channel receptor complex and potentiates t-butyl-bicyclophosphorothionate (TBPS) binding.", "neighbor_flag": "N", "pubmed_ids": [12419014, 14709625, 22522748, 39574417], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "GLVAUDGFNGKCSF-UHFFFAOYSA-N", "cofactor_smiles": "S=C1N=CNC2=C1NC=N2", "cofactor_chem_comp_id": "PM6", "cofactor_name": "Mercaptopurine", "cofactor_resource_id": "DB01033", "mechanism_of_action": "Mercaptopurine competes with hypoxanthine and guanine for the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) and is itself converted to thioinosinic acid (TIMP). TIMP inhibits several reactions that involve inosinic acid (IMP), such as the conversion of IMP to xanthylic acid (XMP) and the conversion of IMP to adenylic acid (AMP) via adenylosuccinate (SAMP). Upon methylation, TIMP forms 6-methylthioinosinate (MTIMP) which inhibits glutamine-5-phosphoribosylpyrophosphate amidotransferase in addition to TIMP. Glutamine-5-phosphoribosylpyrophosphate amidotransferase is the first enzyme unique to the _de novo_ pathway for purine ribonucleotide synthesis. According to experimental findings using radiolabeled mercaptopurine, mercaptopurine may be recovered from the DNA in the form of deoxythioguanosine. In comparison, some mercaptopurine may be converted to nucleotide derivatives of 6-thioguanine (6-TG) via actions of inosinate (IMP) dehydrogenase and xanthylate (XMP) aminase that convert TIMP to thioguanylic acid (TGMP).", "neighbor_flag": "N", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "WSEQXVZVJXJVFP-FQEVSTJZSA-N", "cofactor_smiles": "CN(C)CCC[C@]1(OCC2=C1C=CC(=C2)C#N)C1=CC=C(F)C=C1", "cofactor_chem_comp_id": "68P", "cofactor_name": "Escitalopram", "cofactor_resource_id": "DB01175", "mechanism_of_action": "Escitalopram, like other selective serotonin re-uptake inhibitors, enhances serotonergic activity by binding to the orthosteric (i.e. primary) binding site on the serotonin transporter (SERT), the same site to which endogenous 5-HT binds, and thus prevents the re-uptake of serotonin into the presynaptic neuron.[A185420,A39738,A185726] Escitalopram, along with [paroxetine], is also considered an allosteric serotonin re-uptake inhibitor - it binds to a secondary allosteric site on the SERT molecule to more strongly inhibit 5-HT re-uptake. Its combination of orthosteric and allosteric activity on SERT allows for greater extracellular 5-HT levels, a faster onset of action, and greater efficacy as compared to other SSRIs. [A185825,A185726] The sustained elevation of synaptic 5-HT eventually causes desensitization of 5-HT<sub>1A</sub> auto-receptors, which normally shut down endogenous 5-HT release in the presence of excess 5-HT - this desensitization may be necessary for the full clinical effect of SSRIs and may be responsible for their typically prolonged onset of action.[A185828,A185726]\r\n\r\nEscitalopram has shown little-to-no binding affinity at a number of other receptors, such as histamine and muscarinic receptors, and minor activity at these off-targets may explain some of its adverse effects.[L8513,L8516,L8522,A185726]", "neighbor_flag": "N", "pubmed_ids": [17375980], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "JOZGNYDSEBIJDH-UHFFFAOYSA-N", "cofactor_smiles": "O=C1NC=C(C#C)C(=O)N1", "cofactor_chem_comp_id": "Y3G", "cofactor_name": "Eniluracil", "cofactor_resource_id": "DB03516", "mechanism_of_action": "Normally, 5-FU is rapidly broken down in the body by an enzyme known as dihydropyrimidine dehydrogenase (DPD). Eniluracil irreversibly inhibits DPD, thereby substantially slowing the breakdown of 5-FU and prolonging exposure of the tumor cells to the drug.", "neighbor_flag": "N", "pubmed_ids": [8161345], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "JOYRKODLDBILNP-UHFFFAOYSA-N", "cofactor_smiles": "CCOC(N)=O", "cofactor_name": "Urethane", "cofactor_resource_id": "DB04827", "neighbor_flag": "N", "pubmed_ids": [6689178], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "ZYVXHFWBYUDDBM-UHFFFAOYSA-N", "cofactor_smiles": "CNC(=O)C1=CC=CN=C1", "cofactor_chem_comp_id": "PJH", "cofactor_name": "N-methylnicotinamide", "cofactor_resource_id": "DB08840", "neighbor_flag": "N", "pubmed_ids": [15720138], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "IFSDAJWBUCMOAH-HNNXBMFYSA-N", "cofactor_smiles": "[H][C@@](CC)(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1", "cofactor_chem_comp_id": "40L", "cofactor_name": "Idelalisib", "cofactor_resource_id": "DB09054", "mechanism_of_action": "Idelalisib specifically inhibits P110\u03b4, the delta isoform of the enzyme phosphatidylinositol-4,5-bisphosphate 3-kinase, also known as PI-3K. The PI-3Ks are a family of enzymes involved in cellular functions such as cell growth, proliferation, differentiation, motility, survival and intracellular trafficking, which in turn are involved in cancer. In contrast to the other class IA PI3Ks p110\u03b1 and p110\u03b2, p110\u03b4 is principally expressed in leukocytes (white blood cells) and is important for the function of T cells, B cell, mast cells and neutrophils. By inhibiting this enzyme, idelalisib induces apoptosis of malignant cells and inhibits several cell signaling pathways, including B-cell receptor (BCR) signaling and C-X-C chemokine receptors type 5 and type 4 signalling, which are involved in trafficking and homing of B-cells to the lymph nodes and bone marrow. Treatment of lymphoma cells with idelalisib has been shown to result in inhibition of chemotaxis and adhesion, and reduced cell viability.", "neighbor_flag": "N", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "WOSKHXYHFSIKNG-UHFFFAOYSA-N", "cofactor_smiles": "COC1=C(C=C2C(OC3=CC=C(NC(=O)NC4CC4)C(Cl)=C3)=CC=NC2=C1)C(N)=O", "cofactor_chem_comp_id": "LEV", "cofactor_name": "Lenvatinib", "cofactor_resource_id": "DB09078", "mechanism_of_action": "Lenvatinib is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4). Lenvatinib also inhibits other RTKs that have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression in addition to their normal cellular functions, including fibroblast growth factor (FGF) receptors FGFR1, 2, 3, and 4; the platelet derived growth factor receptor alpha (PDGFR\u03b1), KIT, and RET.", "neighbor_flag": "N", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "LIOLIMKSCNQPLV-UHFFFAOYSA-N", "cofactor_smiles": "CNC(=O)C1=C(F)C=C(C=C1)C1=NN2C(CC3=CC4=C(C=C3)N=CC=C4)=CN=C2N=C1", "cofactor_name": "Capmatinib", "cofactor_resource_id": "DB11791", "mechanism_of_action": "Aberrant activation of c-Met has been documented in many cancers, including non-small cell lung cancer (NSCLC).[A199122] Mutations that result in the skipping of _MET_ exon 14 lead to the formation of a mutant c-Met with a missing regulatory domain - these mutant proteins have a reduced ability to negatively regulate, leading to a pathological increase in their downstream activity.[L13347]\r\n\r\nCapmatinib inhibits the phosphorylation of both wild-type and mutant variants of c-Met triggered by the binding of its endogenous ligand, hepatocyte growth factor - in doing so, it prevents c-Met-mediated phosphorylation of downstream signaling proteins, as well as the proliferation and survival of c-Met-dependent tumor cells.[L13347]", "neighbor_flag": "N", "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"cofactor_in_ch_ikey": "ZCGNOVWYSGBHAU-UHFFFAOYSA-N", "cofactor_smiles": "NC(=O)C1=NC(F)=CN=C1O", "cofactor_name": "Favipiravir", "cofactor_resource_id": "DB12466", "mechanism_of_action": "The mechanism of action of favipiravir is novel compared to existing influenza antivirals that primarily prevent entry and exit of the virus from cells.[A191688] The active favipiravir-RTP selectively inhibits RNA polymerase and prevents replication of the viral genome.[L12075] There are several hypotheses as to how favipiravir-RTP interacts with RNA dependent RNA polymerase (RdRp).[A191688] Some studies have shown that when favipiravir-RTP is incorporated into a nascent RNA strand, it prevents RNA strand elongation and viral proliferation.[A191688] Studies have also found that the presence of purine analogs can reduce favipiravir\u2019s antiviral activity, suggesting competition between favipiravir-RTP and purine nucleosides for RdRp binding.[A191688]\r\n\r\nAlthough favipiravir was originally developed to treat influenza, the RdRp catalytic domain (favipiravir's primary target), is expected to be similar for other RNA viruses.[A191688] This conserved RdRp catalytic domain contributes to favipiravir's broad-spectrum coverage.[A191688]", "neighbor_flag": "N", "pubmed_ids": [30724789], "resource_name": "DrugBank", "resource_version": "5.1", "target_resource_id": "Q06278"}, {"binding_assay_value": 7.4, "binding_assay_value_type": "pIC50", "cofactor_smiles": "CN(C)CCNC(=O)c1cccc2cc3cc(O)ccc3nc12", "cofactor_resource_id": "CHEMBL56149", "neighbor_flag": "N", "pubmed_ids": [20853847], "resource_name": "Pharos", "resource_version": "6.13.4", "target_resource_id": "15989"}], "rcsb_id": "4UHX_1"}